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ABSTRACT
Molecular Cytogenetic Evaluation of Cell Lines and Archival Tissue
Jason Scott White

Uveal melanoma is the most common intraocular tumor in adults and often results
in unilateral blindness and/or death. Previous cytogenetic characterizations of this tumor
have consistently revealed chromosomal abnormalities involving chromosomes 3, 6, and
8; reports of other abnormalities vary in frequency. We further defined cytogenetic
abnormalities of this tumor using molecular cytogenetic techniques on 10 uveal
malignant melanoma cell lines and 100 formalin- fixed paraffin-embedded (FFPE)
tumors.
The synthesis of comparative genomic hybridization (CGH) and spectral
karyotyping (SKY) results revealed that chromosomal rearrangement plays a significant
role in the generation of DNA sequence copy number abnormalities throughout the
genome, but none of the cell lines demonstrated monosomy 3. Centromeric fluorescence
in situ hybridization (FISH) for chromosome 3 revealed approximately one signal per
cell, but further evaluation with telomeric probes demonstrated multiple signals per cell,
suggesting chromosomal rearrangement without the loss of an entire chromosome 3.
Based on combined CGH, SKY and FISH data, we propose that chromosome 3 is more
frequently involved in chromosomal rearrangements rather than whole-chromosome loss
in uveal melanoma.
CGH was similarly employed to elucidate characteristic DNA-sequence copy
number abnormalities of FFPE archival cases of uveal melanoma, and correlate genomic

imbalance abnormalities with a prognosis.

We set out to study 100 archival uveal

melanoma cases, each with comprehensive patient follow- up, by correlation of copy
number imbalances with survival. Fifty-one patients survived more than 9 years without
evident metastasis, and the remaining 49 patients died with metastatic disease. Viable
probe was ge nerated from 82 of the 100 cases, allowing correlation of CGH findings with
patient histories for all but 18 of the cases. Significant copy number imbalances were
tested for univariate prognostic significance. The most powerful predictor of prognosis
was gain of 18q11.2, which was subsequently compared with other significant
chromosomal regions, as well as histological and clinical factors in a multivariate
analysis. Multivariate analyses revealed that the gain of 18q11.2 and concomitant loss of
1p33 was the strongest indicator of a poor prognosis.
Our large-scale molecular cytogenetic analysis of cell lines and archival material
contributes significantly to the characterization of uveal melanoma. This research is
intended to direct further gene-specific study of malignancy in uveal melanoma.

To my parents,
Joan and Hal White,
who have made innumerable sacrifices for my education,
so I could learn without limitations
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INTRODUCTION
Our understanding of cancer continues to evolve as we develop new approaches
in the pursuit of the elusive cure for this multifaceted disease. With each passing day,
either a new technique or a new application of an existing technique propels cancer
research. At times it seems that the more that is discovered about cancer, the more
questions that are encountered. However, significant progress has been made, and will
continue to be made, in this arena.
Pathology is concentrated on the morphology and characteristics of tissue at the
cellular level. The advent of cytogenetic analyses provided insight beneath the level of
the cell, allowing researchers access to information about the chromosome complement
within individual cells (Fig. 1). Classical cytogenetics provides us with a karyotype, or a
catalogue of chromosome homologues, and allows for banding as well as copy number
analysis.

Cytogenetics contributes immensely to cancer research, as chromosome

abnormalities are often associated with the mechanisms underlying carcinogenesis as
well as other disease pathways. Application of in situ hybridization (ISH) methods to
tumor cells yields a variety of information including numerical data and regarding interand intra-chromosomal rearrangements (Cremer et al., 1986; Lichter et al., 1988a;
Devilee et al., 1988; Eastmond and Pinkel, 1989; Trask, 1991; Joos et al., 1994). The
combination of epifluorescence microscopy and in situ hybridization techniques resulted
in fluorescence in situ hybridization (FISH), which is capable of providing chromosome
enumeration, whole chromosome painting, marker identification and gene mapping
(Chang and Mark, 1997).

In brief, FISH is a fairly rapid technique that involves

localization of a labeled deoxyribonucleic acid (DNA) sequence to cellular DNA in

Figure 1. Anatomy of a Nucleus. (A) A stylized drawing of a cell showing a nucleus (gray) containing
DNA in the form of chromosomes. (B ) A single metaphase chromosome from within the
nucleus. (C) Chromosomes are comprised of tightly packed DNA in a double helical
conformation. (D) The DNA is made up of nucleotides, of which specific sequences form the
exons and introns of genes.
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whole tissue, interphase cells or metaphase chromosomes (Fig. 2) (Carpenter, 2001).
FISH spawned comparative genomic hybridization (CGH) and spectral karyotyping
(SKY), which represent more sophisticated applications of molecular cytogenetics
(Kallioniemi et al., 1992; Schröck et al., 1996).
CGH is the comparison of two genomes by hybridization, and is intended to give
researchers the ability to locate DNA copy number anomalies with greater frequency and
increased sensitivity as compared to conventional cytogenetic methodologies. In CGH,
researchers generate fluorescent probes from normal and tumor genomes, and
simultaneously hybridize these probes to normal metaphase spreads (Thompson and
Gray, 1993; Ried et al., 1997). Comparison of the relative fluorescence along each
chromosome results in a ratio profile that shows chromosomal regions of relative gain
(e.g., amplification) and loss (e.g., deletion) in the tumor genome. This is predicated
upon the normal genomic probe binding uniformly to the normal chromosomes, whereas
the tumor genomic probe will show an excess or deficit of specific chromosomes or
portions of chromosomes, thereby revealing gains and losses of chromosomal material
for the tumor.
The development of CGH preceded SKY, which is in essence a genomic scan
using 24-color FISH (Schröck et al., 1996; Macville et al., 1997; Schröck et al., 1997).
In SKY, each of the 22 autosomes and the 2 sex chromosomes are assigned a unique
combination of fluorochromes, which allows for identification of all 24 of the
chromosomes in a single hybridization.

The development of ratio- labeling and

combinatorial labeling schemes, in particular the inclusion of haptens, allowed for the
number of differentially- labeled chromosome paints to exceed the number of

3

Figure 2. Basic FISH Protocol. This schematic outlines the critical steps in FISH. (A) The first step is to
prepare metaphase spreads or interphase nuclei on microscope slides, and age these slides for at
least a week. Pretreatment of the slide may or may not be necessary. (B) Probe is generated via
nick translation or polymerase chain reaction. (C) This probe is placed on the slide and
coverslipped. (D) The slide and probe are simultaneously denatured at or near 75ºC in order for
hybridized probe and target DNA to anneal. (E) The hybridized slide is incubated overnight at
or near 37ºC. (F) On the following day, a post-hybridization wash removes excess unbound
probe from the slide, and the probe is detected using antibody layering schemes as needed. (G)
A DNA counterstain is applied prior to mounting of the slide in antifade solution for
visualization with fluorescence microscopy.
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fluorochromes (Garini et al., 1996; Schröck et al., 1997; Tonon et al., 2000; Schröck and
Padilla-Nash, 2000).

Although the human eye can not resolve the subtle color

differences between some fluorochromes, a Fourier transformation of emitted
fluorescence gives each chromosome a distinct spectrum. Construction of the spectral
karyotype elucidates both numerical and structural, anomalies. This allows determination
of an accurate karyotype of many tumor metaphase spreads, which often contain both
subtle and complex chromosome rearrangements. An additional feature of SKY is that
chromosomal material that can not be karyotyped with confidence in a classical
cytogenetic analysis (such as marker chromosomes) can be correctly identified.
Uveal melanoma is but one of a myriad of cancers afflicting humans today. This
particular solid tumor is the primary intraocular tumor manifested in adults, and results in
loss of vision and in many cases death. Uveal melanoma is any malignant melanocytic
tumor originating in the pigmented vascular layer of the eye including the iris, ciliary
body and choroid (Fig. 3). Epidemiologic studies show that those at greatest risk are
individuals with lightly pigmented skin and/or lightly pigmented eyes (McLean and
Gamel, 1996; Regan et al., 1999). The most frequent chromosomal abnormalities are
found on chromosomes 3, 6, and 8; other chromosomes have been implicated with
varying consistency (Speicher et al., 1994; Prescher et al., 1996; White et al., 1998a).
The tumor is thought to share commonalties with other melanomas, yet maintain its own
defined subset of causal aberrations (Griffin et al., 1988).
In order to ascertain the chromosomal aberrations that contribute to uveal
melanoma, we pursued 2 avenues of research. The first was to employ CGH, SKY and
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Figure 3. Anatomy of the Ocular Globe. This schematic identifies landmarks within the human eye, and
orients the reader with regard to the regions of origin for uveal melanoma. These regions
include the choroid, ciliary body and the iris.
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FISH to provide a complete molecular cytogenetic evaluation of 10 uveal melanoma cell
lines. The second was a comprehensive CGH analysis of 100 archival formalin- fixed
paraffin-embedded (FFPE) uveal melanoma tissue samples.
In the first portion of our study, we characterized 10 uveal melanoma cell lines
(Table 1) by CGH, SKY and FISH to identify chromosome abnormalities.
Characterization of cell lines is often employed as an initial step in characterization and
classification of a disease, as they model the alterations in actual tumors.
melanoma cell lines are typically derived from enucleated tissue.

Uveal

Enucleation, or

removal of the entire globe of the eye, is a common treatment strategy. Cells from
enucleated tissue can be transformed, cultured in an appropriate medium, and maintained
as immortal cell lines for subsequent characterizations (De Waard-Siebinga et al., 1995;
Luyten et al., 1996). Previous characterizations of uveal melanoma cell lines included
not only classical cytogenetic analysis, but also evaluations of specific genes and their
expression (Blom et al., 1997; Luyten et al., 1998; Chana et al., 1999). Uveal melanoma
cell lines have also been used to model the effects of developing or established treatments
(Logani et al., 1995a and b). We expected that a combination of CGH, SKY and FISH
would increase sensitivity for detection of abnormalities, and reveal chromosomal
regions applicable to uveal melanoma diagnosis, prognosis and treatment. We also
expected that the combination of these 3 techniques would ascertain the prevalence of
monosomy 3, as it is a hallmark of uveal melanoma (Speicher et al., 1994; Prescher et al.,
1996; White et al., 1998a).
For the second portion of our study, we analyzed 100 archival FFPE uveal
melanoma cases by CGH. These cases were obtained from the Armed Forces Institute of
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Table 1. Uveal Melanoma Cell Lines Used in this Study
Code

Cell Line

Tumor

Origina

Sexa

Media

1

92-1

primary

choroid

F

RPMI 1640

2

MEL270

primary

ciliary body

M

"

3

MEL285

primary

F

"

4

MEL290

primary

F

"

5

OCM-1

primary

F

Ham's F-12

6

OCM-3

primary

"

7

OCM-8

primary

"

8

OM431

primary

choroid

9

OMM-1

metastatic

subcutaneous metastatic
lesion post-enucleation

OMM-2.3 metastatic

liver metastisis of ciliary
body tumor (MEL270)

10

a

choroid

Referenceb
De Waard-Siebinga et al., 1995
Chen et al., 1997

Kan-Mitchell et al., 1989

"

Albert et al., 1984

M

DMEM

Luyten et al., 1996

M

RPMI 1640

Blank entries reflect data unavailable at the time of the study.
All cell lines provided courtesy of Dr. Jerry Y. Niedercorn and Ms. Elizabeth Mayhew, both at the Department of
Ophthalmology at the University of Texas Southwestern Medical Center at Dallas, in Dallas, TX. Those that have
establishment papers in the published literature have been cited.

b
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Figure 4. Examples of Uveal Melanoma Tumors. Four hematoxylin and eosin (H&E) stained archival
FFPE tissue sections from different uveal melanoma tumor cases. The darkest mass in each
ocular globe (indicated by arrows) is the uveal melanoma tumor.
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Pathology (AFIP) tissue archives, and comprised of 2 slide- mounted 6µm sections of
archival FFPE tumor tissue from enucleated human eyes (Fig. 4). Utilization of archival
tissue allows for analysis of a larger number of cases, particularly when studying a tumor
of low incidence that yields only a few fresh tissue samples each year. Also, archival
FFPE tissue allows for correlation of experimental findings with comprehensive patient
follow-up, such as visible manifestations of the disease, tumor characterization and
grading, patient progress after tumor excision, and survival. Of the 100 cases, 51
survived greater than 9 years without detectable metastasis, and the remaining 49 cases
succumbed to metastatic disease within 9 years of diagnosis. It was expected that the
regions of amplification and deletion seen in the samples from each patient would be
homologous to those seen in the cell line study, and would correlate with survival to
allow determination of prognostic factors associated with uveal melanoma.

Tumor

progression is thought of as a stepwise accumulation of abnormalities in critical genes,
and it was our expectation that some chromosomal regions of gain and loss would
correlate with malignancy and progression of uveal melanoma (Forozan et al., 1997).
Anomalies were tested for univariate prognostic significance, and the most powerful
predictors were compared with other histological or clinical predictors in a multivariate
analysis.
The amalgamation of results from the cell line and archival tumor portions of our
study yielded extensive insight into the chromosome dosage abnormalities characteristic
of uveal malignant melanoma. Further, the synthesis of our results allowed us to identify
not only predictive loci for this tumor, but also to make some speculation about the genes
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involved in development and/or progression of this tumor. Our ultimate goal was to
direct further ge ne-specific study of malignancy in uveal melanoma.
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LITERATURE REVIEW
CYTOGENETICS .
The foremost discovery in genetics was the elucidation of the double- helical
structure of DNA by Watson, Crick, Wilkins and Franklin by X-ray diffraction (Watson
and Crick, 1953). At around the same time, T. C. Hsu first described the use of a
hypotonic gradient to swell a cell, allowing for a closer glimpse of the components within
the cell membrane (Fig. 1) (Hsu, 1952). In his initial work, Hsu found 23 pairs of
autosomes and a pair of sex chromosomes (Fig. 5) (Hsu, 1952). By adapting Hsu’s
technique, Tjio and Levan revised Hsu’s findings of 48 chromosomes, and instead found
that humans have a 46 chromosome complement (Tjio and Levan, 1956). A few years
later, Hungerfo rd and colleagues produced the first karyotype from peripheral blood
culture (Hungerford et al., 1959).
Chromosome banding was developed by Casperson and colleagues in 1968,
providing a useful technique that allowed the entire genome to be analyzed at once
(Casperson et al., 1968; Pinkel et al., 1986a and b; du Manoir et al., 1993). Chromosome
banding analyses are of particular import in cancer research, as chromosomal
abnormalities can be linked with a cancer phenotype, and identification of consistent or
recurrent chromosomal aberrations in tumors is a useful step toward identifying genes
involved in the development or progression of the disease (Macville et al., 1997).
However, analyses of solid tumors are complicated by low mitotic indices and low
quality chromosomal banding, making identification of complex chromosomal
aberrations immensely difficult by banding alone (Macville et al., 1997; Veldman et al.,
1997; Ried et al., 1997; Rothmann et al., 1998).
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Hence, there is a critical need

Figure 5. Anatomy of the Chromosomes. Chromosomes are comprised of 2 arms, the p- and the q-arm,
and the arms are connected by a centromere. The exceptions are the acrocentric chromosomes,
where the p-arm is actually alpha-satellite repeats. Chromosomes can be broken into 3 groups
based on centromere location, and irrespective of size or relative DNA content. (A) The
metacentric chromosomes are defined by their centrally-located centromere, and include 1, 2, 3,
16, 19 and 20. (B) The submetacentric chromosomes have an offset centromere that makes the
p-arm shorter than the q-arm. This group includes 4, 5, 6, 7, 8, 9, 10, 11, 12, 17, 18 and X. (C)
The acrocentric chromosomes are predominantly comprised of q-arm material, but have small
satellites above the centromere, and include 13, 14, 15, 21, 22 and Y.
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to develop more accurate and reliable methods for determination of chromosome
abnormalities.
FLUORESCENCE IN SITU H YBRIDIZATION.
In situ hybridization (ISH) was developed as a means of detecting nucleic acid
sequences in morphologically intact samples (Gall and Pardue, 1969; John et al., 1969).
It is based on the principle that DNA is able to denature and renature in a complementary
fashion (Fig. 6). In principle, two nucleic acid sequences are found to be complementary;
(1) the probe, which is the isolated and tagged sequence that the researcher is interested
in localizing, and (2) the target sequence, which is a length of nucleotides within the
DNA of the sample that matches the probe sequence. When both the sample and probe
are denatured together, and allowed to reanneal, the probe binds to its complementary
sequence in the target DNA. After the DNA has reannealed, the probe can be visualized
and its location pinpointed within the sample.
The first applications of ISH were in 1969, when Gall and Pardue hybridized
radioisotope- labeled ribosomal ribonucleic acid (rRNA) to tissue squashes, revealing the
complementary ribosomal deoxyribonucleic acid (rDNA) in situ (Gall and Pardue, 1969).
Also in 1969, John and colleagues experimented with RNA-DNA hybrids visualized by
autoradiography (John et al., 1969). In the earliest applications of ISH, the nucleic acid
probe (either DNA or RNA) was labeled with a radioisotope, hybridized to its
complementary DNA sequence in a cell or tissue sample, and visualized using
autoradiography (Gall and Pardue, 1969; John et al., 1969). The first non- isotopic ISH
application involved immunofluorescence detection of the RNA-DNA hybrids by a
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Figure 6. Denaturation/Renaturation of DNA. DNA will denature when the ambient temperature is
sufficiently high, and will reanneal when the temperature falls below the melting point. It is
this property of DNA that makes hybridization feasible. In a basic hybridization, the probe
will find its complementary sequence of nucleotides in the target DNA and bind to them,
which functionally incorporates the probe into the target DNA once all of the DNA has had an
opportunity to reanneal. Then, the probe can be visualized and localized within the target
DNA. This simple property of DNA forms the basis for such techniques as ISH, FISH, CGH
and SKY.
This figure was adapted from University of
http://seqcore.brcf.med.umich.edu/doc/educ/dnapr/pg2.html.
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fluorescent antibody bound to the hybrids (Rudkin and Stollar, 1977).

Use of

radioisotope labeling was superceded by applications of non- isotopic conjugated probes
in 1980s (Bauman et al., 1980; Langer et al., 1981; Pinkel et al., 1986b). Bauman and
colleagues described the covalent linkage of tetramethyl rhodamine isothiocyanate
(TRITC) to RNA, which when used simultaneously with a 3 H-labeled complementary
RNA (cRNA) allowed both fluorescence and scintillation quantitation (Bauman et al.,
1980). Technically, this was the first application of a directly- labeled fluorescent probe.
FISH completed its evolution from ISH, by replacing all radioisotopes with
fluorescence labeling (Fig. 2). The first alternatives to labeling with radioisotopes were
biotin- labeled UTP and dUTP, described by Langer and colleagues in 1981 (Langer et
al., 1981). The use of non- isotopic probes has lead to improved resolution, decreased
preparation time and increased probe stability (Trask, 1991).
In 1986, Pinkel and colleagues described the first fluorescent hybridizations
employing biotinylated probes and fluorescently- labeled avidin (Pinkel et al., 1986a and
b).

Indirectly- labeled probes are conjugated with a reporter-binding molecule (or

hapten), whereas directly- labeled probes are conjugated with a fluorochrome (Joos et al.,
1994) (Fig. 7).

Haptens include biotin, digoxigenin, dinitrophenyl (DNP),

aminoacetylfluorene (AAF), mercury and sulfonate (Trask, 1991; Luke and Shepelsky,
1998). Biotin is detected with either a fluorochrome-conjugated avidin or an anti-biotin
antibody, while mercury is detectable with a ligand bearing a sulfhydryl group (Trask,
1991). Digoxigenin and the remaining haptens are detected with fluorescently- labeled
antibodies (Trask, 1991). The use of directly- labeled probes is a more time-efficient
method, and generally results in less background than indirectly- labeled probe
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A.

Fluorochrome conjugated dUTP

UACUAGUCAGUGCGU

B.
Avidin reporter
fluorochrome

Anti-avidin bound
to avidin reporter
fluorochrome

UACUAGCUCGAUGCU

Biotin dUTP

Figure 7. Comparison of Directly- and Indirectly -labeled Probes. (A) Directly-labeled probe. The reporter fluorochrome is directly conjugated to the dUTP,
and visualization of the probe is possible immediately following hybridization. (B ) The indirectly-labeled probe has a hapten-labeled dUTP
incorporated into its sequence, in this case biotin-dUTP, and detection using antibody layering is required following hybridization. An avidin
reporter fluorochrome binds to each biotin-dUTP, and a biotinylated anti-avidin binds to each avidin. A second avidin reporter fluorochrome then
binds to the biotinylated anti-avidin. The antibody layering process is repeated as needed to amplify the probe signal by successive addition of avidin
reporter fluorochrome layers.
This figure courtesy of Dr. Alison E. Director-Myska, AFIP.
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applications upon visualization.

The advantage of direct incorporation of the

fluorochrome into the probe, is that the fluorochrome is confined to the binding site. In
indirect applications, the dyes precipitate around the binding site and are therefore less
specific and result in increased background noise (Demetrick, 1999). However, increased
sensitivity is achieved through the use of an indirectly- labeled probe, which allows for
multiple layers of antibodies, thus increasing the signal intensity.
The advent of FISH narrowed the gap between cytogenetics and molecular
genetics, and gave rise to the field of molecular cytogenetics (Macville et al., 1997).
FISH, as used in molecular cytogenetics, is equally applicable to metaphase spreads,
interphase nuc lei preparations, and tissue sections (Cremer et al., 1986; Lichter et al.,
1988a; Devilee et al., 1988; Eastmond and Pinkel, 1989; Trask, 1991; Joos et al., 1994).
“Interphase cytogenetics” was a term coined by Cremer and colleagues in 1986 for the
detection of chromosome aberrations in interphase cells (Cremer et al., 1986). They later
expanded this definition to include detection in non- mitotic cells at any stage of cell
division, due to modifications made by Lichter et al., (Cremer et al., 1988; Lichter et al.,
1988a).
Lichter and colleagues refined suppression of non- informative regions of repeat,
found in regions such as centromeres, telomeres, heterochromatin, and other families of
repeat sequences in the genome, thus enhancing detection of chromosome-specific
regions of repeat (Lichter et al., 1988a). “Chromosomal in situ suppression” (CISS), a
term first coined in 1988, described the use of unlabeled competitor DNA to suppress of
regions of repeat (Lichter et al., 1988a). These regions of repeat are common on many
chromosomes in the genome, and also are very quick to reassociate after denaturation
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(Lichter et al., 1998a and b). Both of these factors interfere with accurate hybridization
between the probe and target DNA. Incorporation of human Cot-1 DNA inhibits the
binding of repetitive sequences such as the Alu I and Kpn I repeat families (Lichter et al.,
1988a and b). Incorporation of salmon testes DNA binds repeat sequences other than the
two previously mentioned families of repeats, and prevents non-specific binding of the
probe to the slide or coverslip (Lichter et al., 1988a). Each of these are included in the
probe cocktail for suppressive hybridization schemes.
The most important reason for development of interphase FISH techniques, is that
it alleviates the need for metaphase preparations, which are often limited or otherwise
unavailable in tumor preparations (Bayani and Squire, 2002). The use of interphase
nuclei provides higher resolution due to the decreased condensation of nuclear DNA
(Lawrence et al., 1988; Devilee et al., 1988; Joos et al., 1994).
Once the ability to detect a single probe in interphase applications had been
refined, the detection of mulitple targets was the next logical step. A double- labeled
single-target FISH experiment by Cremer and colleagues marked the first multicolor
fluorescence FISH experiment, and a double- labeled double-target FISH hybridization
was carried out in solid tumors shortly thereafter (Cremer et al., 1988; Hopman et al.,
1988). These experiments further demonstrated the increased resolution in interphase
cells as compared to metaphase preparations (Hopman et al., 1988). In 1989, Nederlof
and colleagues were able to detect 3 hybridization targets using a third fluorochrome
spectrally distinct from fluorescein isothiocyanate (FITC) and TRITC (Nederlof et al.,
1989). In 1990, the same group expanded the number of hybridization sites to 4 using the
first combinatorial labeling schemes (involving 2 fluorochromes) (Nederlof et al., 1990).
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At that time, it was postulated that the number of spectrally-distinct fluorescent
hybridization sites could be expanded to 7 using a combination of fluorochromes and
conjugated haptens. The complex hybridization of 7 probes to 7 loci was not realized
until 2 years later (Ried et al., 1992a).
Ried and colleagues were also able to utilize 5 distinct whole chromosome paints
in a single hybridization to assay ploidy of 5 chromosomes critical in prenatal diagnosis
(Ried et al., 1992b). Also in 1992, Dauwerse et al. demonstrated that combining 2
fluorochromes in varying ratios (ratio-labeling) allowed for the distinction of up to 7
whole chromosome paints in a single exposure, significant because the maximum
possible number of distinct loci was also 7 at that time (Dauwerse et al., 1992). They
also suggested that inclusion of a third fluorochrome in their ratio- labeling scheme would
allow distinction of half of the chromosome complement (Dauwerse et al., 1992). FISH
was only limited by the ability to distinguish the spectra of multiple probes in a single
preparation. In other words, the number of hybridization sites was only limited by the
ability of the analysis software and the user to distinguish between different
fluorochromes or combinations of fluorochromes (Joos et al., 1994; Garini et al., 1996).
The evolution of multicolor FISH analyses would eventually lead to development of
genome-labeling techniques, such as multiplex-FISH (M-FISH) and SKY, which allow
distinction of all 22 autosomes and the sex chromosomes in a single hybridization.
Since its inception, FISH has evolved into a technique applicable to dividing or
non-dividing cells in either fresh or archival tissue (Trask, 1991). FISH can be used as an
exploratory or a confirmatory technique. Given an appropriate hybridization scheme,
FISH can be employed to detect inversions, translocations, deletions, dicentrics and ring
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chromosomes (Trask, 1991). The technique itself is generally not very time consuming,
as detection and/or visualization can often be performed a day or two after hybridization.
Specificity of a probe depends on base-pair composition (G-C bonds are stronger than AT), temperature of denaturation and hybridization, as well as the salt and formamide
concentrations in the hybridization mixture (McNicol and Farquharson, 1997).
There are essentially three types of probes currently widespread in use, each with
a slightly different intended application.

The first are locus-specific probes, which,

hybridize to a specific chromosomal locus (Tonon et al., 2000). These probes are
generated from plasmids, phages, cosmids, or YAC-clones (Cremer et al., 1986; Joos et
al., 1994). The efficiency of the hybridization is proportional to the size of the probe,
because the ability to detect a hybridization decreases as the probe size decreases (Trask,
1991). A gene-specific probe, one kind of locus-specific probe, is generated from an
entire gene or a portion of a gene and hybridized to determine where it will localize (e.g.
the location of the ge ne on a chromosome).
The second type of probe is a chromosome-specific repetitive sequence probe,
and this type of probe can be targeted to centromeres (heterochromatin containing
alphoid repeats or alpha-satellite DNA) or telomeres (highly repetitive sequences at the
ends of each chromosome). These probes are typically used in chromosome enumeration
studies, which are focused on determination of the number of copies of a given
chromosome in a preparation (Pinkel et al., 1986b; Eastmond and Pinkel, 1989; Joos et
al., 1994; McNicol and Farquharson, 1997; Demetrick, 1999). Hybridization of these
probes is typically very intense, as the areas hybridized in conserved portions of
heterochromatin are often very compact (Trask, 1991).
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The third type are whole chromosome probes, also known as whole chromosome
paints, which are in actuality a group of probes all generated from a single chromosome
that fluoresce along the length of the entire chromosome when hybridized (Pinkel et al.,
1988). This type of FISH probe is used to identify chromosome-specific material and
determine rearrangements associated with the probed chromosome in the genome
(Tucker et al., 1994; Carter, 1994; Demetrick, 1999). These genomic rearrangements can
be symmetrical (e.g. reciprocal translocations) or asymmetrical (e.g. insertions and nonreciprocal translocations) exchanges (Tucker et al., 1994).

Initially, flow-sorted

chromosomes were used to generate DNA libraries, which were later used to make whole
chromosome paints (Carter, 1994; Joos et al., 1994; Luke and Shepelsky, 1998). Flowsorting remains a viable technique for isolating normal chromosomes for painting, and
can also be used to isolate populations of aberrant chromosomes for production of
painting probes provided the aberrant chromosomes are distinguishable from normal
chromosomes using this technique.

Alternatively, microdissection of specific

chromosomes is possible and allows for aberrant chromosomes to be individually
selected and then used to generate probes (Ried et al., 1997; Bayani and Squire, 2001).
Combination of 24 chromosome-specific paints into a single hybridization cocktail is the
essence of spectral karyotyping, while generation of single-fluorochrome whole genome
probes for CGH applications is an expansion upon the use of whole chromosome paints.
Even though combinatorial and ratio- labeling schemes increased the scope and
application of FISH, it is cumbersome to screen tumor genomes for gains, losses, and
rearrangements with individual FISH probes (Raap, 1995; Raap, 1998).
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COMPARATIVE G ENOMIC H YBRIDIZATION.
In 1992, Kallioniemi et al. developed a molecular cytogenetic technique capable
of detecting and mapping relative DNA sequence copy number differences between 2
genomes competitively hybridized to norma l chromosomes (Kallioniemi et al., 1992). In
this technique, a copy number karyotype is generated for a tumor by comparing the DNA
from malignant and normal cells, thereby identifying regions of gain or loss in the DNA
along the length of each chromosome.

In actuality, the gains and losses are

representative of global genetic variation in the test sample, and the data output is really a
measure of genomic balance (Kallioniemi et al., 1992; Thompson and Gray, 1993;
Houldsworth and Chaganti, 1994; Ried et al., 1997). The inception of CGH was directly
linked to the need for a rapid and comprehensive assessment of genetic balance where
DNA, not cells for culture and chromosome preparation, was the only available material
(du Manoir et al., 1993; du Manoir et al., 1995b; Raap, 1995).
CGH is a quantitative two-color fluorescence in situ suppression hybridization
technique useful in detecting copy number changes throughout an entire genome
(Thompson and Gray, 1993; Ried et al., 1997). In other words, it is essentially doublelabeled double-target FISH, wherein total genomic tumor DNA and total genomic DNA
from normal diploid tissue are differentially labeled and then simultaneously hybridized
to normal metaphase chromosomes. The resulting copy number ratio reveals any genomic
imbalance between the two. CGH is an improvement on single-color hybridizations,
because the normal DNA is an “internal hybridization intensity control” for each location
in the genome (Kallioniemi et al., 1994).
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CGH has numerous advantages, most notably it elucidates gains (e.g.
amplifications) and losses (e.g. deletions) of DNA, often undetectable via classical
cytogenetic techniques. Classical cytogenetic analyses are hindered by the inability to
produce large numbers of high quality tumor metaphases due to low mitotic indices, poor
growth in culture, and the increased likelihood of bacterial and/or necrotic tissue
contamination (Joos et al., 1994; Houldsworth and Chaganti, 1994; Isola et al., 1994). In
CGH, extracted genomic DNA is the only material required from the test sample,
increasing its application to include both fresh and archival tissue (Houldsworth and
Chaganti, 1994; Ghazvini et al., 1996). Karyotypic analysis of solid tumors is difficult
due to the instability of tumor cells in culture, but CGH alleviates the need for in vitro
tumor cell culture, because, in contrast to traditional karyotyping, it only requires DNA
and therefore reduces subpopulation selection (Joos et al., 1994). Imbalances in a subset
of the cells in a given sample do not interfere with the global analysis of the tumor as
long as tumor cells account for most of the DNA (du Manoir et al., 1993; Lundsteen et
al., 1995). However, the effect of intratumor genetic heterogeneity on sensitivity of CGH
is variable, as heterogeneous aberrations in a given sample are averaged while
homogeneous aberrations are emphasized (Kallioniemi et al., 1992; Kallioniemi et al.,
1993). Similarly, if normal tissue accounts for more than 50% of the total DNA from the
test sample, ratio changes may not be reliably detected (Kallioniemi et al., 1994).
As mentioned earlier, one advantage of CGH is the construction of DNA probes
from archival FFPE tissue; this is unique in that the vast majority of cytogenetic
techniques require viable tissue (Isola et al., 1994; du Manoir et al., 1995b). Utilization
of FFPE tissue allows for analysis of a larger number of cases and for correlation of
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experimental findings with comprehensive patient follow-up and survival data. FFPE
tumor analysis allows for investigation of very old samples, however, fixation methods
may negatively affect DNA quality and yield (Isola et al., 1994). In analysis of FFPE
tumors, microdissection of tissue sections, using hematoxylin and eosin (H & E) stained
slides for confirmation, has both advantages and disadvantages. An obvious advantage is
the selection of only tumor material, because, as mentioned earlier, normal cells “dilute”
the CGH results (du Manoir et al., 1993; Houldsworth and Chaganti, 1994; Joos et al.,
1994).

The disadvantages of tumor microdissection lie in the small yield of DNA,

particularly from tissue of reduced cellular density such as the eye. This particular
disadvantage can be overcome by polymerase chain reaction (PCR) amplification of
relatively pure DNA. The use of degenerate oligonucleotide primed-PCR (DOP-PCR)
for small quantities of DNA (as little as 100pg), as first described by Telenius and
colleagues, ensures reliable amplification of the template DNA (Fig. 8) (Telenius et al.,
1992a and b; Speicher et al., 1993; Kallioniemi et al., 1994; Joos et al., 1994). The DOP
primer is actually a family of primers that have a degenerate middle sequence that allows
the primers to bind to more sites within the template DNA, and thereby results in a probe
that more accurately represents the original genomic DNA from the microdissected
tumor.
The primary shortcoming of CGH, is that it does not detect balanced
rearrangements, such as translocations, because there are no copy number gains or losses
associated with such events. For this same reason, point mutations and small intragenic
rearrangements go undetected as well (Kallioniemi et al., 1994; Raap, 1995; Ried et al.,
1997). CGH provides no insight regarding the arrangement of chromosome segments
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Figure 8. DOP-PCR Amplification of Genomic DNA. The 5’ end sequence (gray) is more conserved than
the 3’ end of the primer (white). In between, is a variable six nucleotide sequence that
introduces reduced stringency in to the PCR reaction. (A) In the first PCR cycle, the DOP
primer binds to genomic DNA, and the inherent degeneracy of the primer combined with the
reduced stringency of a relatively low annealing temperature allows it to bind with diminished
specificity as compared to conventional PCR primers. The polymerase extends the sequence in
the 3’ direction from the sequence of primer attachment. (B) In the cycles that follow, the
annealing temperature is still sufficiently low to allow relatively uniform amplification of all
genomic sequences. (C) In the subsequent cycles, the annealing temperature is increased with
each cycle, eventually requiring that the entire length of the primer binds to the template strand.
This figure was adapted from Telenius et al., 1992a.
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involved in reported gains and losses, nor does it help explain the origin of marker
chromosomes.

Further, the technique has no application for instances of clonal

heterogeneity, since it only detects aberrations present in a majority of cells in a given
sample (du Manoir et al., 1993; Raap, 1995; Ried et al., 1997; Chang and Mark, 1997).
In such instances, abnormalities may cancel one another or be too infrequent to detect
(Kallioniemi et al., 1994). Since CGH only detects copy number changes relative to the
average copy number it can not distinguish genomic changes in ploidy, as there is no
difference in the test:reference ratio between or within specific chromosomes in these
cases (Kallioniemi et al., 1994). Sensitivity of detection for deletions is related to ploidy
level as well; it is easier to detect a single copy loss in a diploid test sample than in a
triploid or tetraploid test sample (Kallioniemi et al., 1994). Copy number changes are
also difficult to quantify, even if they are not the result of aneuploidy, as the fluorescent
signal tends to spread over a region greater than the length of the amplicon. This
presumably results from the complex organization of the target DNA (Kallioniemi et al.,
1992).

An additional limitation is that some chromosomal aberrations will not be

detected because they occur in regions smaller than can be resolved by CGH, which has a
resolution of approximately 10-20Mb (Kallioniemi et al., 1992; Kallioniemi et al., 1993,
Thompson and Gray, 1993). Therefore, such regions are only detected when the level of
amplification is high (5-10 fold for 1Mb region) (Thompson and Gray, 1993;
Houldsworth and Chaganti, 1994; Raap, 1995; du Manoir 1995b; Forozan et al., 1997).
CGH is predicated upon appropriate chromosome classification of the normal target
metaphase, whether by the software, the user, or an interaction between the two.
Chromosome classification is an inherent source of error, as misclassification seriously
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affects the results, and it is also the greatest limiting factor in the processing of CGH data
(Raap, 1995, Lundsteen et al., 1995).
Image preparation is of paramount importance in CGH.

Homogeneity in an

image is usually recognizable given a uniform reference paint. Homogeneity is highest
when hybridizing a directly- labeled probe, reduced with indirectly- labeled probe, and
reduced again with multiple layers associated with signal amplification of an indirectlylabeled probe (Lundsteen, 1995). Reduced homogeneity is akin to increased granularity
or improperly sized probe, and indicative of a poor hybridization. The spread of the
metaphase chromosomes, image realignment due to pixel shift between filter changes,
and proper plane of focus all merit consideration in the processing of CGH images (du
Manoir et al., 1995a).

Selected metaphases should be of a similar degree of

condensation, but some CGH analysis packages compensate for variations in
condensation by normalization through linear stretching to fit the profile (Lundsteen,
1995; du Manoir et al., 1995b). Criteria for a good metaphase for analysis are as follows:
(a) hybridization is smooth and high in intensity; (b) test (green) and reference (red)
distributions are similar among sister chromatids; (c) background is low and uniform; (d)
binding at centromeres and other regions of repeat is minimal; and (e) chromosomes are
of acceptable morphology providing for adequate 4’,6-diamidino-2-phenylindole (DAPI)
banding and there are few or no overlaps (Kallioniemi et al., 1994). A minimum of 5 to
10 examples of each chromosome should be measured. In our lab, the preference was for
10 metaphases, which should yield 20 measurable examples of each chromosome. It
should be noted that analysis of many chromosomes is not a substitute for quality
hybridizations (du Manoir et al., 1995a and b).
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Fundamentally, CGH results are a comparison of green to red fluorescence
intensities. These intensities are integrated along the length of each chromosome for both
chromatids, and the result is the green:red ratio profile. Copy number gains and losses
are determined by assigning absolute thresholds to the ratio profiles. Thresholds are
determined by desired sensitivity, and may be adjusted to compensate for ploidy if a
determination using independent methods is possible (du Manoir et al., 1993; du Manoir,
1995b). All of the green:red ratio profiles collected across all chromosomes represent the
copy number karyotype (ratio comparisons) for test (green) and reference (red) samples.
The copy number karyotypes from multiple metaphases are combined to reduce noise
from spread variation and enhance “visibility” of true copy number aberrations in a given
test sample (Kallioniemi et al., 1994; Piper et al., 1995).
Regions of repeat must be suppressed to accurately measure ratios in adjacent
chromosomal regions.

Typically, these centromeric, heterochromatic and telomeric

regions are partly suppressed with human Cot-1 DNA and salmon testes DNA, but still
vary widely in copy number (either extremely high or low) (Kallioniemi et al., 1994; du
Manoir et al., 1995b; Ried et al., 1997). This variation in heterochromatin is elevated if
the test and reference are of different donors (du Manoir et al., 1993; Kallioniemi et al.,
1994). Similar difficulties are encountered with telomeric DNA.
Thompson and Gray suggested that CGH be enhanced by follow-up with FISH to
detect or confirm changes in chromosome number, translocations, inversions, or
derivative chromosomes (Thompson and Gray, 1993). While this remains true, a more
sensitive and revealing analysis on a per-cell basis was made available with the
introduction of SKY. In consideration of all of the benefits of CGH, the most notable
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downside to the technique is the inability to detect the chromosomal structure underlying
the gains and losses (Houldsworth and Chaganti, 1994).

The development of SKY

fostered the detection of most structural rearrangements, and allowed for a more
complete molecular cytogenetic analysis of tumors when used in conjunction with CGH.
SPECTRAL KARYOTYPING.
FISH has become an integral technique in cancer research and other cytogenetic
diagnoses, but the field of molecular cytogenetics benefits greatly from FISH-based
techniques that screen the entire genome (Schröck et al., 1996; Macville et al., 1997;
Schröck et al., 1997). SKY is one such technique wherein the structural and numerical
analysis of all chromosomes is made possible by a combinatorial labeling scheme and
advances in image acquisition and analysis (Schröck et al., 1997; Schröck and PadillaNash, 2000). Unlike CGH, SKY is only applicable to fresh material capable of cell
division (Schröck et al., 1996; Ried et al., 1997). One of the most attractive features of
this technique, is the ability to identify chromosomal aberrations rapidly and without any
previous indication of the abnormalities, as the technique explores the entire genome in a
single hybridization (Cohen et al., 1997; Rothmann et al., 1998). In addition, the
chromosomal composition of previously unclassified marker chromosomes is revealed
(Rothmann et al., 1998; Bayani and Squire, 2001). In essence, SKY is the ideal hybrid of
the functionality of CGH and FISH; it provides a screen of an entire genome, like CGH,
with the sensitivity of FISH for detection of structural and numerical chromosomal
aberrations (Chang and Mark, 1997; Schröck et al., 1997).
In particular, this technique facilitates a differential display of all human
chromosomes in a color karyotype using 24 distinct colors, with a resolution of 1-2Mb
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(Macville et al., 1997; Rothmann et al., 1998; Tonon et al., 2000; Bayani and Squire,
2001). Whole chromosome probes are generated via DOP-PCR and differentially labeled
with various combinations of 5 fluorochromes, thus producing 24 distinctly colored
paints (Garini et al., 1996; Schröck et al., 1997; Tonon et al., 2000; Schröck and PadillaNash, 2000). Typically, 3 of the fluorochromes are directly incorporated into the probes
via fluorochrome-labeled dNTPs (rhodamine, Texas-Red or Spectrum Orange, FITC or
Spectrum Green, and Cy3). The other 2 are incorporated via hapten-coinjugated dNTPs,
typically detected with avidin Cy5 and mouse anti-dig Cy5.5, and sometimes amplified
further by antibody layering (Garini et al., 1996; Macville et al., 1997; Tonon et al.,
2000). Inclusion of unlabeled competitor DNA (i.e. Cot-1 and salmon testes DNA), as
previously described for CGH and FISH, allows for suppression hybridization and
contributes to accurate chromosome painting and resolution of chromosome
abnormalities (Macville et al., 1997).
As stated earlier, a specific color is assigned to each chromosome using a
combination of these direct and indirect labels. SKY is similar to M-FISH, in that each
technique uses combinatorial labeling to identify chromosomes.

The use of

combinatorial labeling allows for the number of targets to exceed the number of
fluorochromes, particularly given the breadth of hapten-labeling and detection schemes
(Garini et al., 1996; Macville et al., 1997; Ried et al., 1997; Garini et al., 1999). Basic
FISH applications are hampered by the fact that the spectra of the available
fluorochromes overlap, and therefore it is not possible to define 24 separate probes (Ried
et al., 1997).

However, M-FISH overcomes this by detecting each fluorochrome

separately using a set of applicable filters, and requires separate image captures and
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subsequent overlay prior to image analysis (Speicher et al., 1996). On the other hand,
SKY simultaneously excites all fluorochromes and determines the emission spectra, or
peak intensity and wavelength, at each pixel in a single image for the entire metaphase
spread (Schröck et al., 1996; Ried et al., 1997; Rothmann et al., 1998; Lee et al., 2001).
Spectral imaging, the foundation for SKY, is based upon a combination of
spectroscopy and imaging (Garini et al., 1996; Macville et al., 1997; Ried et al., 1997;
Rothmann et al., 1998). Spectroscopic analysis is centered around a stained histological
specimen that when illuminated, either absorbs or reflects the light, and emits photons
revealing the properties of the dye (Rothmann et al., 1998). The hybridization itself is
fairly similar to other FISH-based protocols, and only a single CCD image capture is
required for SKY analysis. After exposure through a triple bandpass filter, which excites
all dyes simultaneously and blocks excitation light from the emission path, a Sagnac
interferometer creates an optical path difference in the light emitted from the painted
chromosomes (Fig. 9). An interferogram is generated for every pixel during the CCD
image capture; this is a measure of emitted spectra in terms of intensity at a given
wavelength (Schröck et al., 1996; Garini et al., 1996; Macville et al., 1997; Ried et al.,
1997; Raap, 1998; Rothmann et al., 1998; Garini et al., 1999). The differences in the
captured spectra may be visualized in the display colors of the CCD image. A Fourier
transformation ensures that subtle changes in intensity and wavelength between similar
spectra are assigned drastically different classification colors, or pseudo-colors, to allow
appropriate discrimination (Schröck et al., 1996; Garini et al., 1996; Macville et al.,
1997; Ried et al., 1997; Raap, 1998; Garini et al., 1999; Bayani and Squire, 2001).
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Multiple FISH probes can be used to query several genes at once, but the ability
to simultaneously paint all 24 human chromosomes is a powerful tool for performing a
global analysis of the chromosome complement of a given cell. Independently, FISH can
not accommodate enough spectrally distinct fluorochromes for a global analysis, and
SKY will not distinguish submicroscopic deletions, para- or peri-centric inversions, or
small duplications or deletions that do not alter the size or composition of the
chromosome (Garini et al., 1996; Veldman et al., 1997; Chang and Mark, 1997).
Therefore, the combination of SKY and FISH in a single preparation is a very useful tool
for looking at the involvement of a specific gene in a rearrangement event, and is a
unique refinement on employing each technique individually and attempting to
synthesize the results (Tonon et al., 2000). Combination of these 2 techniques allows the
researcher to assay the involvement of a specific gene and of specific chromosomes in a
given rearrangement using a single preparation.

SKY may also be employed as a

screening technique for gene or chromosome involvement, perhaps best applied
following an expression study such as serial analysis of gene expression (SAGE) or
microarray analysis (Ried et al., 1997; Tonon et al., 2000).
Tumors, in particular solid tumors, often have complex karyotypes with multiple
rearrangements in the genome (Ried et al., 1997; Tonon et al., 2000). While SKY
remains very useful for such applications, it has the potential for misclassification,
commonly due to fluorescence signal flaring that obscures a breakpoint or otherwise
interferes with interpretation by the SKY software (Lee et al., 2001). Although the
resolution of SKY is estimated at 1-2Mb, actual resolution hinges upon the degree of
chromatin condensation (Macville et al., 1997; Schröck et al., 1997; Bayani and Squire,

33

Figure 9. Schematic for SKY Image Capture and Analysis. The principle of spectral karyotyping is
spectral imaging, which allows distinction of spectrally-overlapping fluorochromes in a SKY
hybridization. Emitted light is visualized through a triple bandpass filter (A), the light is then
passes through a Sagnac interferometer (B), and the image is captured in a single exposure
using a CCD camera (C). The interferogram seen in (C) is the pixel-by-pixel detail of
wavelength and intensity across the entire captured image. (D) The interferogram is analyzed
using Fourier transformation to determine the spectrum of the light at each pixel. The spectra
for the entire image can be visualized directly as an RGB image (E) similar to the image seen
through the microscope. Alternatively, each pixel is classified and the image is pseudocolored
(F) to distinguish overlapping fluorochromes.
This image was adapted from Schrock et al., 1996.
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2001). An additional drawback is the cost associated with SKY hybridization, making it
potentially most effective as an initial screen of a number of cells prior to a thorough
analysis with a specific target for FISH or a comprehensive CGH analysis (Lee et al.,
2001; Bayani and Squire, 2001). The combination of SKY with CGH allows for an
amazingly powerful analysis to resolve structural and numerical chromosome aberrations,
at which point the inclusion of FISH becomes useful as a confirmatory assay (Macville et
al., 1999).
UVEAL M ELANOMA.
Uveal melanoma is the primary intraocular tumor observed in adults, and often
results in blindness and/or death. Epidemiological studies show an incidence of
approximately 6 per million per year in the Caucasian population; within this population
it is more common in lightly pigmented individuals (McLean and Gamel, 1996). Lightly
pigmented eyes are also demonstrated to be more susceptible to the melanoma (Regan et
al., 1999). The clinical course of the cancer is related to the size of the tumor, the cell
type, and the variability of the nucleolar size (Gordon et al., 1994; Prescher et al., 1996).
Additional considerations include gender, wherein males are slightly more susceptible
than females, and predisposing factors (McLean and Gamel, 1996).
Previous studies have shown that oculo(dermal) melanocytosis, neurofibromatosis
type 1, Li-Fraumeni syndrome, and familial atypical mole and melanoma (FAM-M)
syndrome are predisposing factors (Singh et al., 1996a; Kincaid, 1998). Due to the
strong link between sunlight and cutaneous melanoma, researchers have also considered
sunlight as a potential cause for uveal melanoma; the results have been ambiguous
(Tucker et al., 1985; Egan et al., 1988; Holly et al., 1990; Dolin et al., 1994). There have
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been rare cases of familial uveal melanoma, thought to be inherited in an autosomal
dominant fashion and as yet unlinked to any genetic locus or cytogenetic anomaly (Lynch
et al., 1968; Singh et al., 1996a; Singh et al., 1996b).
In relation of gross pathology to prognosis, the most significant feature of this
solid tumor is the largest tumor dimension (LTD) (Hungerford, 1993; McLean and
Gamel 1996). Lesions are considered small if the LTD is at or below 10mm, medium if
the LTD is 11-15mm, and large if the LTD exceeds 15mm (McLean and Gamel, 1996).
The prognosis worsens as the tumor increases in size. Other features, including vascular
supply, are far less significant (Kincaid, 1998).
Uveal melanomas may arise in the choroid, ciliary body, or the iris (Fig. 3). The
origin of the tumor has prognostic significance, with melanomas originating in the iris
having the most favorable prognosis (Hungerford, 1993; Kincaid, 1998). Iris melanomas
are the least common, while choroidal melanomas are the most common (Hungerford,
1993; McLean and Gamel, 1996; Kincaid, 1998; Singh et al., 2001).

Choroidal

melanomas often rupture the Bruch’s membrane and invade the subretinal space, giving
them a characteristic mushroom shape (McLean and Gamel, 1996; Kincaid, 1998).
Ciliary body tumors can later invade the iris. Clinical diagnosis may occur following
routine examination of a asymptomatic eye, blurring or loss of vision, pain from
inflammation, or retinal detachment and intraocular hemorrhage (McLean and Gamel,
1996).
Uveal melanoma tumors are generally classified based on cell type, using a
modified version of the Callender classification system (Callender, 1931; McLean et al.,
1983; McLean and Gamel, 1996).

In this system, uveal melanomas containing
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epithelioid cells are designated “mixed-cell type,” melanomas without epithelioid cells
are termed “spindle-cell type,” and tumors with too much necrosis to be classified by
cytology are designated “necrotic type.”
Approximately 50% of patients die from hematogenous metastasis (McLean and
Gamel, 1996). Metastasis occurs hematogenously, due to the lack of a lymph system in
the eye, and almost exclusively localizes to the liver. The preferential metastasis to the
liver is not well understood, but can no t be explained through lymphatic drainage
pathways (McLean, 1995).
The process of hematogenous metastasis is sequential, where each step is fully
completed before the following step can take place. Interruption of the metastatic process
translates into a cure for the patient. The stepwise process of hematogenous metastasis is
as follows: growth and local invasion of primary site, neovascularization, vasular
invasion, embolization, transport to the metastatic site, arrest at the metastatic site,
extravascularization at the metastatic site, growth and neovascularization, growth of
tumor cells in newly established metastasis, and finally re- metastasis (Fidler, 1990;
McLean, 1993). Survival time is primarily a function of the growth rate of tumor cells,
because this determines the pace of the metastatic process. The significance of lead time
and tumor burden (also known as LTD) are thereby decreased in uveal melanoma. Lead
time is the length of time between metastasis and treatment, and its significance is
decreased because metastases are often not discovered prior to removal of the eye. The
relevance of tumor burden on survival time is decreased, because the exponential growth
of a tumor has a larger effect on tumor size than pronosis since the critical number of
doubling times before metastasis can ot be estimated (McLean, 1993). In addition,
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patient to patient variation in tumor size decreases the strength of this prognostic
indicator. The mean of the diameters of the 10 largest nucleoli, measured from at least 50
fields of the tumor, has been found to be a good predictor of survival; “the larger the
nucleoli the lower the cure-rate and the shorter the median survival time” (McLean, 1993;
McLean, 1995; Periera et al., 2001). This measurement is similar, but slightly different,
in cutaneous melanoma, where the mean of the 10 largest nuclei, rather than nucleoli, is
of prognostic significance (Periera et al., 2001). Survival time following metastasis is
also dependent on the immunologic defense system of the host, which is primarily tumorinfiltrating lymphocytes (TIL). In most solid tumors, presence of TIL are associated with
a better prognosis; for indeterminate reasons, the opposite is true when infiltration occurs
in uveal melanoma (McLean, 1993; McLean, 1995; McLean and Gamel, 1996).
The primary treatment for uveal melanoma is enucleation, or removal of the eye.
Conservative therapies include radiation and eye-wall resection, with the intent of
preserving the eye and maintaining vision (McLean and Gamel, 1996; Kincaid, 1998).
Radiation therapy is done using a precisely focused particle beam or a radioactive plaque
sutured to the sclera beneath the tumor. Eye-wall resection can be used on medium or
small tumors (≤15mm), but is not feasible on large tumors (>15 mm) (McLean and
Gamel, 1996).

Survival studies are in progress to compare prognosis and survival

following enucleation or more conservative therapies, such as radiation and resection
(Hungerford, 1993; McLean and Gamel, 1996).

The conservative treatments are

currently favored in smaller tumors, which researchers hope will one day result in tumor
control and preservation of vision (Kincaid, 1998).
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Investigations at the sub-cellular level have begun to unveil the genetics
underlying tumor development, progression, and metastasis.

Cytogenetic evidence

indicates that copy number abnormalities prevail within uveal melanoma (Gordon et al.,
1994; Speicher et al., 1994; Ghazvini et al., 1996). Results from cytogenetic analyses
suggest that the most frequent abnormalities occur in chromosomes 3, 6, and 8;
monosomy 3 is associated with a poor prognosis (Speicher et al., 1994; Prescher et al.,
1996; White et al., 1998a). Monosomy 3 is seen in uveal melanoma of the ciliary body,
whereas disomy or polysomy of chromosome 3 are reported in choroidal melanoma
(Sisley et al., 1993; McNamara et al., 1997). Abnormalities of chromosome 6 are also
seen in cutaneous melanoma, which suggests the cancers may share some common
genetic alterations (Griffin et al., 1988). Other recurrent abnormalities have been noted
with varying consistency, including those on 7q, 9p, and 13q (Gordon et al., 1994).
Evidence suggests a bifurcated pathway for tumor progression, wherein an
aberration of either chromosome 3 or 6 occurs, eventually followed by alteration of
chromosome 8 and metastasis. Chromosome 8 abnormalites are not seen unless
accompanied by an aberration of chromosome 3 or 6 (Parella et al., 1999).
Due to its strong link with prognosis, chromosome 3 copy number is frequently
assayed in the uveal melanoma research community. Monosomy 3 was first identified
using classical cytogenetic techniques, and was generally reported in 50% of the tumors
studied (Horsman et al., 1990; Sisley et al., 1990; Prescher et al., 1990; Horsthemke et
al., 1992; Sisley et al., 1992; Horsman and White, 1993; Wiltsire et al., 1993; Singh et
al., 1994; Prescher et al., 1994; Prescher et al., 1995; Prescher et al., 1996; White et al.,
1998b; Parada et al., 1999; Sisley et al., 2000; Tschentscher et al., 2001). Similar results

39

were found by hybridization-based techniques, including analyses of chromosome 3 loss
using FISH (Wiltshire et al., 1993; Sisley et al., 1997; Naus et al., 2002). CGH studies
report monosomy with similar frequency as well (Speicher et al., 1994; Gordon et al.,
1994; Prescher et al., 1996; Ghazvini et al., 1996; Tschentscher et al., 2001; Naus et al.,
2001). Studies employing a combination of these methods offer an internal validation of
their findings (Wiltshire et al., 1993; Prescher et al., 1996; Tschentscher et al., 2001).
However, the comprehensive cytogenetic characterization of uveal melanoma remains
incomplete, largely because most studies involve small sample sizes almost exclusively
comprised of fresh material.
The absence of chromosome 3, 6, and 8 abnormalities in some cases, suggests that
there are additional pathways of malignant transformation (Singh et al., 1996a). Several
papers seem to refute or question the bifurcated model of development (White et al.,
1998b; Sisley et al., 2000; Naus et al., 2001). This indicates that while there may be
exclusivity with regard to the sequence in which chromosome abnormalities appear in
some tumors, it does not hold true in every case. Alternatives to monosomy 3 have also
been reported recently, and are starting to receive some attention. Decreases in copy
number of chromosome 3 have sometimes been reported in lieu of monosomy, where
CGH showed a tendency toward loss of a portion of the chromosome rather than
complete loss (Gordon et al. 1994; Ghazvini et al., 1996). LOH studies have
demonstrated losses on either arm of the chromosome rather than along the length of the
entire chromosome (Sisley et al., 1993; White et al., 1998a; Parella et al., 1999; Myatt et
al., 2000; Tschentscher et al., 2001). Furthermore, isodisomy of chromosome 3, trisomy
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3, and tetrasomy 3 have been reported in the literature (McNamara et al., 1997; White et
al., 1998a).
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MATERIALS and METHODS
H UMAN PERIPHERAL BLOOD LYMPHOCYTE (HPBL) CULTURE.
Venipuncture was performed on healthy and karyotypically normal male and
female donors with informed consent, and 0.8ml blood was added to 10ml RPMI 1640
media (Invitrogen Life Technologies, Carlsbad, CA) supplemented with 20% FBS
(Sigma Co., St. Louis, MO), 100µl penicillin/streptomycin (100U/ml and 100µg/ml,
respectively) and 1% sodium heparin (Invitrogen Life Technologies, Carlsbad, CA).
Then, 216µl phytohemagglutinin (PHA) (Invitrogen Life Technologies, Carlsbad, CA)
was added to each T-25 culture. The cultures were incubated at 37°C in 5% CO2 for 72
hours.
UVEAL M ELANOMA CELL LINES .
Ten uveal melanoma cell lines were obtained from the Department of
Ophthalmology, University of Texas Southwestern Medical Center at Dallas (Dallas,
TX), and maintained in culture using standard techniques (Table 1). The cell lines were
derived from 8 primary uveal melanomas and 2 metastases.
M ETAPHASE CHROMOSOME PREPARATIONS .
We prepared metaphase chromosome spreads from normal, cultured human
peripheral blood lymphocytes (HPBL) and cultured cell lines via conventional techniques
(Tucker et al., 1994).

After 72 hours of culture, 0.1µg/ml, or 100µl, of colcemid

(Karyomax Colcemid Solution, Invitrogen Life Technologies, Carlsbad, CA) was added
to each culture flask. Cultures with colcemid were incubated an additional 15 minutes,
after which the T-25 cultures were gently agitated and transferred to 15ml conical
centrifuge tubes, and centrifuged at 1200rpm for 8 minutes.
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The supernatant was

aspirated, the cell pellet resuspended in 5ml of a 75mM KCl (see appendix) hypotonic
solution pre-warmed to 37°C, and incubated for 20 minutes at 37°C. The hypotonic
solution was used to swell the cells, eventually causing the cells to burst and release their
chromosomes when dropped onto slides, forming metaphase spreads. Following
incubation, the addition of 2ml fresh Carnoy’s fixative (see appendix), and subsequent
centrifugation for 8 minutes at 1200rpm, stopped the swelling of the cells.

The

supernatant was again aspirated, and the cells resuspended in 5-10ml fresh fixative. The
cells were centrifuged, the supernatant aspirated, and the pellet resuspended.

This

process was repeated until the cell pellet appeared to be clean and completely white upon
visual inspection.
At this point the cells were dropped onto slides; alternatively, the cells were
resuspended in fixative, stored upright at 4°C and dropped onto slides within the next few
days. The best results were observed when slides were dropped on the same day as the
harvest. In order to make metaphase slide preparations, the supernatant was aspirated
and the cells resuspended in approximately 0.5-1ml glacial acetic acid with a 200µl
pipette after the final centrifugation. A clean slide, swabbed with ethanol until free of
debris, was placed over an 80°C water bath and misted with dH2 O. The pipette tip was
loaded, and 2 adjacent drops of the cell suspension were placed onto the slide from a
height ranging from 6 inches to 3 feet above the slide. The slide was dried over the water
bath, checked for quality, stored in a slide box to age for approximately 1 week. For
long-term storage, aged slides were kept in a slide box with desiccant, flushed with
gaseous nitrogen, sealed in a plastic bag and kept at -20°C until needed.
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NUCLEI PREPARATIONS .
For FISH analysis, nuclei from the uveal melanoma cell lines and a normal male
donor were harvested from 25ml culture flasks using the procedure for metaphase spread
preparation, but in the absence of colcemid (Tucker et al., 1994). Nuclei preparations
were aged and stored in the same manner as the metaphase preparations.
UVEAL M ELANOMA TUMOR CASES .
One hundred FFPE uveal melanoma tumors were selected at random from the
AFIP tissue archives.

Two 6µm tissue sections per case were available for

microdissection, and were accompanied by photocopies of corresponding H & E stained
slides for tumor identification (Fig. 4). Of these cases, 51 patients (23 male, 28 female)
survived more than 9 years without evident metastasis, and the remaining 49 patients (29
male, 20 female) succumbed to metastatic disease. Determination of gender was required
for appropriate hybridization, but no other patient characteristics were revealed until
completion of the analysis.
M ICRODISSECTION.
Initial approaches involved using a sterile razor blade to scrape the entire paraffin
tissue section from the slide for DNA isolation. It was found that the quality of the DNA
was improved if the tumor was exclusively excised from the slide. Microdissection is a
useful technique for ensuring the highest possible proportion of tumor cells, with as few
contaminating normal cells in the sample as possible (du Manoir et al., 1993; Kallioniemi
et al., 1994). Microdissection was performed on two 6µm tissue sections for each of 100
uveal melanoma cases. The accompanying H & E slides were used to locate and isolate
the uveal melanoma tumor in the FFPE tissue section. A sterile 20-gauge needle, a sterile
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razor blade, or a fresh microtome blade was used in manual microdissection of the tumor
tissue from the slide. The tumor tissue from both tissue sections was combined in a
single 1.7ml microcentrifuge tube for each case to ensure the availability of sufficient
tumor DNA for DOP-PCR; this was a concern due to the variability in tumor size from
case to case.
DNA ISOLATION.
Normal (reference) DNA.
Reference samples for the entire study were collected via venipuncture from a
single normal male and a single normal female donor with informed consent, and the
majority of blood was aliquoted into T-25 flasks for culture of HPBL as previously
described. A small volume of blood was set aside for isolation of whole genomic DNA;
the addition of 200µl whole blood to a microcentrifuge tube yielded approximately 35µl
purified DNA upon completion of the isolation protocol.
The isolation protocol began with the addition of 20µl RNase A (see appendix)
(Roche Molecular Biochemicals, Indianapolis, IN) to 200µl whole blood, mixed by
vortexing.

Then, 25µl 20mg/ml Proteinase K (Roche Molecular Biochemicals,

Indianapolis, IN) and 200µl cell lysis buffer (see appendix) were added to the tube,
vortexed thoroughly, and incubated for 10 minutes at 70°C. Proteinase K digestion
increased the yield of high molecular weight DNA (Isola et al., 1994). Then, 500ml
phenol/chloroform/isoamyl alcohol solution (PCI) (25:24:1, v/v) (Invitrogen Life
Technologies, Carlsbad, CA) was added to the tube(s) after removal from the oven, and
then the tube was vortexed again.

This was followed by a full speed (14,000rpm)

centrifugation for 5 minutes in a microcentrifuge. The upper aqueous layer was removed
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and put into a clean microcentrifuge tube, and another 500µl PCI was added, again
followed by vigorous vortexing.

The tube(s) was spun at full speed for another 5

minutes. The upper layer was again removed and placed into a clean tube.
The following reagents were then added to this solution: 25µl 3M sodium acetate
(Quality Biological, Inc., Gaithersburg, MD), 1.5µl 20mg/ml glycogen (Roche Molecular
Biochemicals, Indianapolis, IN), and 100% ethanol at volume equal to 3x the volume of
the tube. The tube was again vortexed to ensure an evenly distributed solution, and
incubated at -20°C for up to 2 hours.

The DNA was precipitated via full speed

centrifugation for 5 minutes. The supernatant was aspirated, 0.5ml 85% ethanol added to
the pellet, and vortexed thoroughly. Following a second 5 minute centrifugation at full
speed, the ethanol was decanted, and the 85% ethanol wash repeated. The resulting
supernatant was aspirated, and the pellet of DNA in the bottom of the tube was dried in a
lyophilizer set on high for 5 minutes. The pellet was finally resuspended in 35µl TE
buffer (pH 7) (see appendix) for long-term storage at -20°C. DNA quantification was
performed using a GeneQuant II (Pharmacia Biotech, Cambridge, England); the 260/280
ratios and DNA concentration recorded.
Cell Line DNA.
DNA was extracted from uveal melanoma cell lines maintained in culture. The
media was removed from the T-25 flask and set aside. Two milliliters of 1xTrypsinEDTA (Mediatech, Inc., Herndon, VA) were added to the flask, and when the cells were
fully suspended in the Trypsin-EDTA solution, the media was replaced into the flask.
The contents of the flask were pipetted into a 15ml conical centrifuge tube, and
centrifuged at 1500rpm for 6 minutes. The supernatant was aspirated, and the cell pellet

46

was washed twice in 10ml 1xPBS (w/o MgCl2 or CaCl2 ); each time the supernatant was
aspirated. The cell pellet was resuspended in approximately 1ml of 1xPBS (w/o MgCl2
or CaCl2 ) following the second wash. The sample was pipetted from the 15ml conical
tube into microcentrifuge fuge tubes in 200µl aliquots. From this point on, the DNA
isolation procedure was identical to that described for normal HPBL DNA.
Tumor (test) DNA.
Following microdissection, as previously described, tumor DNA was extracted
via a protocol similar to that described earlier for normal DNA. First, 800µl Hemo-De
(Fisher Scientific, Inc., Pittsburgh, PA) was added to each tube containing microdissected
tumor tissue.

Following addition of Hemo-De, the tubes were vortexed, and 400µl

ethanol were added. The tube was vortexed again, and centrifuged at full speed for 5
minutes. The supernatant was decanted, and 800µl ethanol was added. Once again, the
tube was vortexed and centrifuged at full speed for 5 minutes. The supernatant was
decanted, and the pellet dried in a 55°C oven for 5 minutes. Then, 250µl cell lysis buffer
and 25µl 20mg/ml Proteinase K were added to the tube, and vortexed thoroughly. The
tube(s) was incubated overnight at 55°C in an Eppendorf Thermo Mixer (Brinkmann
Instruments, Inc., Westbury, NY). The remainder of the DNA isolation protocol, from
PCI extraction through DNA quantification, was identical to that described for normal
DNA.
NICK TRANSLATION.
For the cell line CGH experiments, all whole genomic probes were generated via
nick translation of extracted DNA (Fig. 10).

Each 50µl nick translation reaction

contained the following reagents: 1µg DNA (volume variable), 5µl 10xNT buffer (see
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Figure 10. Probe Production via Nick Translation. Genomic DNA is randomly nicked with Dnase I, after
which DNA Polymerase I excises nucleotides in the 3’ to 5’ direction. Then, the same
polymerase will replace the patch of excised nucleotides using the available pool of dNTPs.
Due to the decreased ratio of dTTP in the dNTP mixture, hapten- or fluorochroms -labeled
dUTP will be preferentially incorporated. The dUTP is labeled, but the preferential
incorporation is not skewed enough to cause steric hindrance of the resulting labeled probe
DNA.
This figure courtesy of Dr. Alison E. Director-Myska, AFIP.
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appendix), 5µl dNTP mixture (see appendix), 5µl 0.1M ß-Mercaptoethanol (see
appendix), 2µl of either biotin-16-dUTP or digoxigenin-11-dUTP (Roche Molecular
Biochemicals, Indianapolis, IN), with the remainder being sterile H2 O. The solution was
vortexed, 5µl 1:1000 DNase I (see appendix) (Roche Molecular Biochemicals,
Indianapolis, IN) and 1µl Kornberg polymerase (Roche Molecular Biochemicals,
Indianapolis, IN) were added. The reaction tubes were incubated for 2 hours at 15°C.
Following the incubation, 5µl samples of each reaction were run on a 1.7% agarose gel
(see appendix) to size the fragments. After the labeled DNA fragments were sized by
agarose gel electrophoresis and ethidium bromide visualization by UV (ultraviolet)
excitation, optimal probe size was seen as a smear of DNA between 200- and 1000-bp in
length (Fig. 11) (Kallioniemi et al., 1994; Houldsworth and Chaganti, 1994). To load the
gel, 5µl nick translation product were added to 0.5µl loading buffer (see appendix), and
at least 1 well was loaded with a 100bp ladder (Roche Molecular Biochemicals,
Indianapolis, IN). If the probe length exceeded 1000bp in length, additional DNase I was
added, and the reaction continued at 15°C with size checks every 30 to 60 minutes. If the
probe was smaller than 200bp, it was discarded and a new reaction was set- up. Once the
probe was in the appropriate size range, 1µl 0.5M EDTA (Digene, Gaithersburg, MD)
was added and tubes were incubated at 65°C for 10 minutes to halt the reaction; the
probes were available for immediate use, or could be stored at -20°C until needed.
POLYMERASE CHAIN R EACTION (PCR).
Whole genomic probes, for the tumor study, were generated through DOP-PCR,
as first described by Telenius and colleagues (Fig. 8) (Telenius et al., 1992a and b).
DOP-PCR, accepted as an accurate method of probe creation for CGH, results in larger
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Figure 11. Agarose Gel Electrophoresis Comparing DNA Extracts with Nick Translation Products.
Phenol/chloroform/isoamyl alcohol (PCI) extraction procedures were used to isolate normal
DNA from normal male and female donors, as well as each of ten uveal melanoma cell lines.
Whole genomic probes were generated through nick translation of extracted DNA, and
normal DNA and tumor DNA genomic extracts were labeled with digoxigenin-11-dUTP and
biotin-16 dUTP, respectively (Roche Molecular Biochemicals, Indianapolis, IN). The
resultant labeled DNA fragments were measured via agarose gel electrophoresis, visualized
with ethidium bromide staining coupled with visualization through UV excitation, and
determined to be between 200 and 1000 base pairs in length. Lane 2 is the DNA molecular
weight marker XIV 100 base pair ladder (Roche Molecular Biochemicals, Indianapolis, IN).
Lanes 3 and 4 are normal male DNA extract and nick-translated male DNA, respectively.
Lanes 5 and 6 are cell line extract from an uveal melanoma cell line and the nick-translated
probe product, respectively.
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labeled fragments than nick translation (Kallioniemi et al., 1994).

This technique,

frequently applied when there was a small volume of the template DNA available,
reliably amplifies quantities of DNA as small as 100pg (Speicher et al., 1993). Haptenlabeled dUTP was included in the DOP-PCR reaction mix to allow probes to be
visualized indirectly (Fig. 12).

Reference and tumor DNA were labeled with

digoxigenin-11-dUTP and biotin-16-dUTP, respectively.
DOP-PCR primers were obtained with the sequence 5’- GAT CAA GCT NNN
NNN ATG TGG - 3’ (Integrated DNA Technologies, Inc., Coralville, IA). Amplification
was performed using a GeneAmp PCR System 9700 thermocycler (PE Applied
Biosystems, Foster City, CA). Each 100µl DOP-PCR reaction mixture contained the
following reagents: 10µl of a 1:25 dilution of test or reference DNA in TE Buffer, 10µl
10x PCR Buffer II (w/o MgCl2 ) (Roche Applied Biosystems, Foster City, CA), 10µl
20mM DOP Primer (see appendix), 24 µl 25mM MgCl2 (Roche Applied Biosystems,
Foster City, CA), 5µl biotin- or dig-dNTP mixture (see appendix), 39µl sterile H2 O, and
2µl AmpliTaq Gold (see appendix) (Roche Applied Biosystems, Foster City, CA). All
reagents, except the DNA, can be combined into a DOP-PCR master mix (PCR MM) (see
appendix) to simplify PCR set-up. Conditions were as follows: 95°C for 10 minutes
initial soak, 15 cycles of 94°C for 1 minute, 30°C for 1 minute, 72°C for 1 minute, and
then 60 cycles of 94°C for 30 seconds, 52°C for 30 seconds, 72°C for 1 minute with a 1
second per cycle addition to each step in the 60 cycles, and completed with a final
extension of 72°C for 10 minutes before a hold at 4°C. Labeled DNA fragments were
sized by agarose gel electrophoresis and ethidium bromide visualization by UV
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excitation. Optimal probe size was seen as a smear of DNA between 200- and 1000-bp
in length (Kallioniemi et al., 1994; Houldsworth and Chaganti, 1994).
COMPARATIVE G ENOMIC H YBRIDIZATION.
In brief, slides were first pretreated in order to remove unwanted cytoplasm and
protein from the metaphase preps. Indirectly- labeled reference and tumor probes were
simultaneously hybridized to the normal metaphase chromosomes. Following a 2-night
hybridization, the indirectly- labeled probes were detected using antibody layering
detection procedures, and as a final step, the slides were counterstained and coverslipped
prior to visualization via fluorescence microscopy (Fig. 13).
Slide pretreatment for hybridization involved several steps. Initially, slides were
equilibrated in 2xSSC (see appendix) at room temperature.

Following a short

equilibration period, 200µl of a 1:200 dilution of 20mg/ml RNase A stock (see appendix)
in 2xSSC was applied to each slide, and the slides were incubated in a hybridization
chamber at 37°C for 1 hour. Three washes in 2xSSC for 5 minutes each, complete the
digestion of RNA from the slide. Then, slides were treated with a solution prepared from
15µl 100mg/ml pepsin stock solution (see append ix) added to 50ml of pre-warmed 37°C
0.01M HCl, and the slides incubated in a 37°C oven for 6 minutes. After the pepsin/HCl
treatment (see appendix), the slides were washed twice in 1xPBS (w/o MgCl2 or CaCl2 )
(see appendix) for 5 minutes, followed by a third 5- minute wash in 1xPBS/MgCl2 (see
appendix).

Postfixation was performed in a 50ml solution of 1% formaldehyde in

1xPBS/MgCl2 (see appendix) for 10 minutes, followed by a single 5- minute wash in
1xPBS (w/o MgCl2 or CaCl2 ) prior to slide dehydration in a series of 3 ethanol dilutions
(70%, 85%, and 100%) for 3 minutes apiece, which completes the slides.
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Figure 12. DNA Probe Production via PCR. The process of PCR, simplified, is a series of DNA
denaturation, annealing of primers, and extension of the DNA. The primers are specific for
sequences within the target DNA to be amplified. When two primers bind within an
allowable proximity, the polymerase will create complementary lengths of DNA in the 5’ to
3’ direction. If a labeled dUTP is incorporated in the dNTP mixture, and the ratio of dTTP is
reduced, the dUTP will be incorporated with increased frequency without resulting in steric
hindrance. Repetition of the cycle many times amplifies the pool of labeled target DNA
probe sequence.
This figure courtesy of Dr. Alison E. Director-Myska, AFIP.
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Figure 13. A Flowchart for CGH. This is intended as a general description of the steps for CGH, and is
elaborated upon in Figures 14, 15, and 18. The preparation of normal target metaphases
occurs in parallel with the preparation and labeling of normal and tumor genomic DNA. Both
DNA probes are simultaneously hybridized to the pre-treated target slide, and following a 2night hybridization, the indirectly-labeled probes are detected. For image processing, the
target metaphase is captured using DAPI, FITC, and TRITC filters. The combination of
images captured using each filter creates a CGH overlay image suitable for analysis.
This figure was adapted from Institut für Pathologie, University Hospital Charité,
http://amba.charite.de/cgh/protocol/02/prot02.html.
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Figure 14.

A Schematic of the Process of Hybridization for CGH. The process begins with the
preparation of genomic DNA, wherein DNA is extracted from tumor and normal cells.
Extracted DNA is digested (NT) or amplified (PCR) into shorter fragments, or lengths of
nucleotides, and during that process the DNA is also labeled with a hapten. Equimolar ratios
of the labeled tumor (test) and normal (reference) DNA are simultaneously hybridized to a
pre-treated slide of normal male metaphase spreads. The hybridized area is sealed beneath a
coverslip (dashed outline), and incubated for 2 nights. On the third day, the slide undergoes
post-hybridization washes to remove excess probe, and fluorescence antibody detection for
the hapten-labeled genomic probes. To complete the slide, the normal target metaphase
chromosomes are counterstained with DAPI, and mounted in an antifade solution for image
processing, which includes image capture and analysis .
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CGH was performed as described by Kallioniemi and colleagues (Fig. 14)
(Kallioniemi et al., 1992). The normal and tumor probes, created via DOP-PCR, were
combined into a single probe cocktail. To make and precipitate the probe cocktail, 30µl
each (tumor and reference) DOP-PCR product, 60µl human Cot-1 DNA (Invitrogen Life
Technologies, Carlsbad, CA), 1µl salmon testes DNA (Sigma Co., St. Louis, MO),
12.1µl 3M sodium acetate, and 400µl ice cold absolute ethanol were combined in a
microcentrifuge tube for each case to be hybridized. The DNA was precipitated by
incubation at -20°C for 2 hours. Precipitate was collected by a 30- minute centrifugation
at 14,000rpm. The supernatant was decanted, and the probe pellet was lyophilized for 5
minutes. Then, 5µl molecular grade formamide (Fisher Scientific, Inc., Pittsburgh, PA)
was added to each pellet, vortexed, and incubated at 37°C for 30 minutes. Afterwards,
10µl hybridization master mix (see appendix) was added, the mixture was vortexed and
denatured at 80°C for 5 minutes, followed by a 2-hour pre-anneal at 37°C. One hour and
forty minutes into the preanneal, 100µl of 70% formamide/2xSSC (FA/SSC) (see
appendix) was added to each pretreated slide along with a 24x60mm glass coverslip. The
slides were immediately incubated in an 80°C oven for 1.5 minutes, and then dehydrated
in a series of ethanol dilutions (70%, 85%, and 100%) for 3 minutes each. The slides
were dried, and the pre-annealed probe applied to the denatured slides. The hybridized
slides were then covered with a 22mm2 coverslip and sealed with Elmer’s rubber cement
(Elmer’s Products, Inc., Columbus, OH), and incubated at 37°C for 2 nights prior to
detection.
On the third day, the solutions for detection were pre-warmed for 1 hour before
the procedure was started. Then, the rubber cement and coverslips were removed. The
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slides were then washed at 45°C in 50% FA/SSC (see appendix) 3 times for 5 minutes
per wash. This was followed by another three 5-minute washes in 0.1xSSC at 60°C, and
then the slides were dipped in 4xSSC/0.1% Tween 20 (see appendix) pre-warmed to
37°C. A blocking solution of 3% bovine serum albumin (BSA) (Sigma Co., St. Louis,
MO), pre-warmed to 37°C, was applied, and the slides were placed in a hybridization
chamber at 37°C for 1 hour. The slides were again dipped in 4xSSC/0.1% Tween 20 prewarmed to 45°C, before the first layer of antibodies was applied. For antibody layering,
100-200µl of a given antibody layer solution was applied to each slide, plastic coverslips
were placed over the solution, and the slides were again placed in a hybridization
chamber for 1 hour at 37°C, followed by three 5-minute washes in 4xSSC/0.1% Tween
20 pre-warmed to 45°C. This process of washing, layering, incubating was repeated for 4
layers. The layers were as follows: layer 1 = 1:200 avidin-conjugated FITC (Vector
Labs, Burlingame, CA) and 1:100 mouse-anti- DIG (Sigma Co., St. Louis, MO), diluted
in 1% BSA (see appendix); layer 2 = 1:200 biotinylated anti-avidin (Vector Labs,
Burlingame, CA) and 1:200 rabbit anti- mouse TRITC (Sigma Co., St. Louis, MO),
diluted in 1% BSA; layer 3 = 1:200 avidin-conjugated FITC in 1% BSA; and layer 4 =
1:200 goat anti-rabbit TRITC (Sigma Co., St. Louis, MO).

Antibody layering was

necessary to amplify the fluorescence signal prior to image capture and analysis.
Following antibody detection procedures, slides were counterstained with DAPI (Sigma
Co., St. Louis, MO) (see appendix). Finally, a coverslip was mounted over an antifade
solution (see appendix) to complete each of the slides.
While some copy number alterations were obvious given the variation in green
and red colorization in the hybridization, quantitative fluorescence analysis of digital
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images was required for accurate CGH analysis (Raap, 1998). Image acquisition and
analysis were performed on a Leica Q550CW cytogenetics workstation, which included a
LEICA DM-RXA fluorescent microscope (Fig. 15) (Leica Inc., Exton, PA), and a SenSys
cooled CCD camera (Photometrics Ltd., Tuscon, AZ). A CCD camera was mounted on
the microscope for image capture and import into the software. DAPI, FITC, and TRITC
images were acquired separately and combined to create a CGH image of each metaphase
spread suitable for analysis in the Leica QCGH software (Fig. 16). Each image was
visualized using an appropriate single bandpass filter, thus there was limited overlap in
excitation and emission spectra (Joos et al., 1994; du Manoir et al., 1995a). Inverting the
DAPI image approximated G-banding for accurate karyotyping of each metaphase spread
(Fig. 17) (Trask, 1991). Compilation of CGH ratio profiles from a minimum of 10
metaphase spreads per cell line, allowed the generation of mean ratio profiles in the form
of green:red (test:reference DNA) fluorescence ratios (Fig. 18). Ninety- five percent
confidence intervals were applied to each of the collective means. The copy number
thresholds for gain and loss were 0.2 units above or below the midline (1.2 and 0.8).
While significant gains and losses were observed on the sex chromosomes, information
on the sex of the parent tumor was not available for all cell lines (Table 1). Therefore,
our cell line analysis considered only the autosomes.
SPECTRAL KARYOTYPING.
SKY was performed using the SkyPaint™ hybridization kit (Applied Spectral
Imaging, Inc., Carlsbad, CA) and results were visualized using the SkyVision™ spectral
imaging system (Fig. 9) (Applied Spectral Imaging, Inc., Carlsbad, CA). Metaphase
spreads were prepared from each of the uveal melanoma cell lines via conventional
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A.

B.

C.

Figure 15. Step-wise Process of CGH Visualization. (A) The captured FITC and TRITC images are
combined to form a single overlay image. (B) This image is combined with the DAPI
counterstain to yield a completed CGH image. (C) The resultant image from (B) is
karyotyped. In the completed color karyotype, similar variations in the amount of bound test
probe are seen in homologous chromosome pairings. See Figure 16 for additional detail
regarding image capture.
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A.

B.

C.

D.

Figure 16.

Image Capture for CGH Analysis. Each of these images is the identical normal male
metaphase spread detected with three different fluorescent filters. (A) The metaphase
chromosomes counterstained with 4’,6-diamidino-2-phenylindole (DAPI) (Sigma Co., St.
Louis, MO). Biotinylated tumor DNA signals were detected with avidin-conjugated
fluorescein isothiocyanate (FITC) (Vector Labs, Burlingame, CA), and digoxigenin -11dUTP-labelled normal DNA was visualized using tetramethylrhodamine is othiocyanate
(TRITC) conjugated antibodies (Sigma Co., St. Louis, MO). (B ) The FITC image, and (C)
the TRITC image. These three fluorescent images (A, B and C) combine to form (D) the
completed CGH image. This newly combined image is suitable for CGH analysis; the image
is classified and karyotyped, followed by the generation of CGH profiles to illustrate the
amplifications and deletions present within the tumor genome. All image acquisition was
performed using a Leica Q550CW cytogenetics workstation which includes a Leica DMRXA fluorescent microscope (Leica Inc., Exton, PA) and a SenSys cooled CCD camera
(Photometrics Ltd., Tuscon, AZ).
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A.

B.

C.

Figure 17. DNA Counterstain. (A) The counterstained metaphase spread stained with DAPI. (B) The inversion of the DAPI counterstain yields banding
patterns comparable to G-banding, and allows for accurate karyotyping of the metaphase spread chromosomes. (C) For comparison purposes, a Gbanded image from a different metaphase spread.
Image (C) was adapted from Genetics of Cancer Resource Center, http://www.intouchlive.com/cancergenetics/chrm-anl.html.
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Figure 18. A Schematic for the Process of CGH Analysis. In (A), the completed karyoptype from Figure 12 results in a (B) fluorescence ratio profile (red:green
for reference:test), where each homologue has its own profile tracing as seen in blue. In (C), compilation of a minimum of 10 ratio profiles comprises
the mean ratio profile, in which 95% confidence intervals are assigned to the data. Also shown are the gain (green) and loss (red) bars along the
length of the ideogram, which correspond to the mean gains and losses in the test sample. In (D), the side-by-side comparison of all sample mean
profiles results in a QPD comparison (1) and the derivation of minimal common regions (2) from the comparison of means.
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cytogenetic techniques as described previously.

Fresh slides were aged at room

temperature for a week and then hybridized with SkyPaint™ probes as per the
manufacturer’s instructions.

Selected metaphase slides were treated with 6µl pepsin

stock solution in 50ml of 0.01M HCl for 5 minutes, washed twice in 1xPBS (w/o MgCl2
or CaCl2 ) for 5 minutes, once in 1xPBS/MgCl2 , and then dehydrated in a series of ethanol
dilutions (70%, 85%, and 100%) for 2 minutes each. The SkyPaint™ probe mixture was
denatured by incubation at 80°C for 7 minutes followed by a pre-anneal incubation at
37°C for 1 hour.

Pretreated slides were denatured by incubation with 100µl 70%

FA/SSC for at 80°C for 1.5 minutes. Ten microliters of denatured, pre-annealed probe
was applied to the denatured, pretreated slides, a coverslip was placed atop the probe and
sealed with rubber cement (Elmer’s Products, Inc., Columbus, OH) prior to incubation at
37°C for 2 nights.

On the third day the rubber cement seals and coverslips were

removed. The slides were washed once in 50% FA/SSC at 45°C for 5 minutes, twice in
1xSSC (see appendix) at 45°C for 5 minutes each, and finally in 4xSSC/0.1% Tween 20
at 45°C for 2 minutes. Eighty microliters of the manufacturer-supplied blocking reagent
was applied, the slides were coverslipped, and incubated at 37°C for 30 minutes.
Following the blocking step, the coverslips were removed and 80µl antibodies, supplied
as buffer 1 (Applied Spectral Imaging, Inc., Carlsbad, CA), were applied. Slides were
incubated at 37°C for 45 minutes followed by 3 washes in 4xSSC/0.1% Tween 20 at
45°C for 3 minutes each. Eighty microliters of a second set of antibodies, supplied as
buffer 2 (Applied Spectral Imaging, Inc., Carlsbad, CA), were applied and the slides were
incubated at 37°C for 45 minutes. Following this incubation, the slides were washed 3
times in 4xSSC/0.1% Tween 20 at 45°C for 3 minutes each and once in dH2 O for 2
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minutes. The slides were allowed to dry, 20µl of manufacturer-supplied DAPI/antifade
solution was applied, and a coverslip was mounted over each slide. A minimum of 3
metaphase spreads per cell line were captured and analyzed using the SpectraCube and a
SkyVision™ workstation.

While CGH data is stored in the form of CCD images

captured through various filters, data from a spectral image is captured in a single
exposure and stored in three dimensions, the x and y planes and the integration of light
intensity on a wavelength scale, hence the use of the term “cube” in SpectraCube
(Rothmann et al., 1998).
INTERPHASE FLUORESCENCE IN SITU H YBRIDIZATION (FISH).
Interphase FISH was performed on uveal melanoma cell lines, created via
metaphase chromosome preparation techniques, using human chromosome 3-specific
centromere (3cen) probe (Cambio Ltd., Cambridge, UK).

Application of the slide

pretreatment protocol for CGH prior to hybridization removed any RNA, cytoplasm, or
proteins complexed with the DNA (Kallioniemi et al., 1992). The protocol consisted of
treating the normal male and cell line slide preparations with RNase A, pepsin/HCl, and
1% formaldehyde in 1xPBS/MgCl2 , and lastly dehydration in a series of ethanols (70%,
85%, and 100%), prior to denaturation and hybridization. The hybridization protocol for
the 3cen probes was a slight modification of the manufacturer’s instructions for
optimization. Pretreated slides were denatured in 70% FA/SSC at 70°C for 5 minutes,
dehydrated in a series of ethanols and allowed to air dry on a 37°C slide warmer.
Denaturation of 20µl of indirectly- labeled (biotinylated) 3cen probe at 75°C for 5
minutes occurred in parallel with slide denaturation and dehydration. The probe was
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applied to the slide, sealed under a 22mm2 glass coverslip with Elmer’s rubber cement,
and allowed to hybridize for 16 hours at 37°C.
Following hybridization, the coverslips were removed, and the slides washed
twice in 45°C 50% FA/SSC for 5 minutes, and then twice in 45°C 0.4xSSC for 5
minutes.

The slides were dipped in 45°C 4xSSC/0.05% Tween 20 (see appendix),

incubated for 1 hour at 37°C with 150µl 3% non-fat dried milk (NFDM) blocking
solution (see appendix), and then dipped in 4xSSC/0.05% Tween 20 a second time. Each
slide had 100-200µl of a given antibody solution layered onto it, and slides were
incubated for 1 hour with each of 3 separate antibody layers. The first layer of antibodies
consisted of avidin-FITC and avidin- Rhodamine in 3% NFDM, the second layer was
biotinylated anti-avidin, and the third layer was identical to the first. Following each
antibody layer, slides were washed 3 times for 5 minutes each in 45°C
4xSSC/0.05%Tween 20. After the final wash, slides were counterstained with DAPI,
rinsed with dH2 O for 5 minutes, and dehydrated in a series of ethanols (70%, 85%, and
100%) for 3 minutes each. Finally, a glass coverslip was mounted over an antifade
solution to complete each of the slides. Visualization of the dual-colored probe was with
the Leica Q550CW cytogenetics workstation, as described for CGH. FITC, TRITC, and
DAPI images were acquired separately and combined to view signal localization and
score signal counts within the nuclei. Two hundred nuclei per cell line were scored for
3cen signals. We closely adhered to the rules for analysis of signal distribution as set out
by Herrington and colleagues, and the criteria for interphase FISH as described by
Hopman et al. (Hopman et al., 1988; Herrington et al., 1995).
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Interphase FISH was performed on uveal melanoma cell lines using directlylabeled telomere probes fo r 3p (FITC) and 3q (Texas Red) (Cytocell Ltd., Banbury,
Oxfordshire, UK). Slide pretreatment was identical to that described for 3cen FISH.
Tandem hybridization of the telomere-3 probes followed the manufacturer’s instructions,
except for the substitution of a 22mm2 glass coverslip. Codenaturation of the probe and
slide on a Vysis Hybrite block (Vysis Inc., Downer’s Grove, IL), sealed together under a
22mm2 glass coverslip, preceeded overnight hybridization in a humidified chamber at
37°C. Slides were treated using the manufacturer’s post-hybridization protocol, stained
with DAPI and mounted with antifade as described above. Again, 200 nuclei per cell line
were scored for 3p and 3q signals, and published criteria for interphase FISH and
guidelines for analysis of signal distribution were adopted (Hopman et al., 1988;
Herrington et al., 1995). Image capture was identical to that described for the 3cen
hybridization.
Hardware requirements for FISH analysis are similar to those described for other
molecular cytogenetic techniques.

For our purposes, the hardware requirements

described for CGH digital imaging microscopy were sufficient. Hybridized slides were
scored using a Leica Q550CW cytogenetics workstation, which includes a LEICA DMRXA fluorescent mic roscope (Leica Inc., Exton, PA), and a SenSys cooled CCD camera
(Photometrics Ltd., Tuscon, AZ). Use of a CCD camera is the most sensitive method for
obtaining high quality digital fluorescence images (Joos et al., 1994).
STATISTICAL ANALYSES .
Extensive quantitative manipulations of the data from the cell line study were
necessary in order to compare the results from CGH, SKY and FISH analyses. In the
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tumor study, statistical analyses were used in order to isolate regions of prognostic
significance.
Cell Line CGH Analysis.
To effectively malipulate the CGH data from the cell line study, a pixel
quantification of net area under each ratio profile curve was applied using a Visual Basic
v. 6.0 (Microsoft Corp., Redmond, WA) program created for Image Pro Plus v. 4.5
(Media Cybernetics, Silver Spring, MD) for each of the chromosomes in a given cell line.
The intent was to extrapolate the extent of genomic imbalance represented by each of the
profiles contributing to the mean. In other words, analyses were made to determine the
quantity of shift from the midline of the profile represented in the CGH data given the
addition or subtraction of the amount of chromosomal material shown to be gained or lost
for a given chromosome. Analysis of individual profiles rather than the mean profiles
was determined to be the most accurate approach, similar to an approach previously
applied to pseudodiploid and pseudotriploid test samples (Rosenberg et al., 1997). The
following formula was applied to calculate relative balance (RB) represented in each
individual chromosome profile in all metaphase spreads analyzed for each cell line:
CGH RB = (NA/PL x 1/len1) + 1
For a given chromosome, NA was the number of pixels under ratio profile to the right of
the midline minus the number of pixels under the ratio profile to the left of the midline,
PL was the vertical profile pixel length, in pixels, and len1 was the distance, in pixels,
representing a unit change in copy number on the x-axis of the ratio profile. CGH RB,
the extrapolated ratio value used as a measure of balance, was determined for a specific
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chromosome in any given cell for each of the cell lines. This allowed a quantification of
the expected amount of genomic imbalance relative to the copy number ratio.
Cell Line SKY Analysis.
A pixel quantification of each of the 24 chromosome classification colors in SKY
was applied using a Visual Basic v. 6.0 (Microsoft Corp., Redmond, WA) program
written for Image Pro Plus v. 4.5 (Media Cybernetics, Silver Spring, MD).

This

quantification was performed for each of the available spreads from the 10 cell lines, and
normalized against representative whole chromosomes from within the same spread. The
relative chromosome equivalent (RCE) feature was calculated for each of the 22
autosomes from the SKY classification images according to the formula:
SKY RCE = PT/PN
For a metaphase spread, PT was the number of pixels designated for a given
chromosome throughout the SKY classification image, and PN was the number of pixels
assigned to all cytogenetically normal chromosomes of the same classification divided by
the number of normal chromosomes counted. This internal normalization resulted in
determination of relative chromosome equivalents for each cell line. Using this method,
the relative amount of genomic imbalance could be compared between chromosomes
from a given cell line, but SKY RCE remained an absolute measure of chromosomal
material and therefore was directly comparable with the FISH results.
A relative genomic balance for the SKY data (SKY RB) was calculated for each
of the 22 autosomes by dividing the individual chromosome SKY RCE values by the
mean SKY RCE (comparable to CGH midline) for all chromosome types. The SKY
data, an absolute measure in its original form, becomes transformed into a ratio and was
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thereby compensated for ploidy but not aneusomy. SKY RCE and SKY RB results for
OCM-3 were not reported due to hardware failure while archiving SKY data.
Cell Line FISH Analysis.
A FISH relative chromosome equivalent (FISH RCE) feature was calculated for
chromosome 3 in each cell line, as the sum of all 3cen, 3p and 3q hybridization signals
(200 nuclei scored for each) divided by the total number of signals (divided by 600).
This was essentially a combined average for the individual signal means. FISH RCE
remained an absolute measure of chromosome 3 copy number, and was most readily
compared with the SKY RCE. Since there was no available compensation for genomic
ploidy, because FISH revealed only chromosome 3 copy number, determination of FISH
RB was not reasonable.
Tumor CGH Analysis.
Minimal common regions were generated from mean ratio profiles of 82 archival
FFPE tumor specimens analyzed by CGH, for those chromosomal regions evidencing
gains or losses in greater than 30% and less than 70% of the cases. Minimal common
regions were further subdivided by gender, for accurate analysis of copy number
imabalnces on the sex chromosomes, and survival, to determine which chromosomal
regions were potentially of value in prognosis.
CGH data for individual cases was recorded as normal (1), gain (2), loss (0), or
both (0 and 2) at each minor band for all 24 chromosomes in the mean ratio profiles.
Minor band data was collated for each major band, and major bands were initially
scanned for significant gains or losses with a two-tailed t-test. Only those chromosomal
regions shown to be significant in the analysis of major bands were then analyzed at the
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level of the minor band, also with a two-tailed t- test.

Individual minor bands with

univariate significance following that analysis were compared with cell type, tumor size,
mean of the ten largest nucleoli, and survival in a Cox Regression analysis, to determine
which chromosomal regions correlate most strongly with prognosis. Univariate KaplanMeier cause specific survival curves were generated for those regions determined to have
prognostic significance in the Cox Regression analysis.

Multivariate predictors of

prognosis were also explored, as first described by McLean and colleagues, and
multivariate Kaplan-Meier cause specific survival curves were also generated (McLean et
al., 1977).

70

RESULTS
UVEAL M ELANOMA CELL LINES .
Comparative Genomic Hybridization.
Mean profiles for all 10 cell lines were compared (Fig. 19).

Copy number

abnormalities identified in greater than 50% of the mean ratio profiles comprise the
minimal common regions, which were pinpointed based upon the most recent
chromosome ideogram and genome mapping data available (Fig. 20).
Many of these abnormalities aligned with previously published findings,
including CGH and classical cytogenetic data (Tables 2 and 3).

Minimal common

regions were used to identify genes likely to be involved in uveal melanoma (Table 4).
Many of these genes have either been previously linked to uveal melanoma or its
predisposing factors and/or are involved in cell-cycle control.
Gains and losses often consisted of large portions of chromosomes, and in some
cases involved whole chromosomes.

Whole chromosome gains were observed in

individual cell lines: chromosome 7 (OMM-1), chromosome 8 (MEL270) and
chromosome 17 (OCM-3). Whole chromosome gains were observed in 3 cell lines for
chromosomes 20 (OCM-3, OCM-8, and OMM-1) and 22 (OCM-3, OCM-8, and OMM2.3). The greatest gains of chromosome 3 were evidenced in OCM-1, OM431, and
OMM-2.3. Only OCM-1 and OM431 had gains that included the centromere. Other
significant p- and q-arm gains were seen in OCM-3 and OCM-8. A whole chromosome
loss was observed in one instance on chromosome 4 (OCM-3).
The frequent involvement of chromosomes 3, 6 and 8 in copy number imbalances
was apparent (Figs. 19 and 20). There were multiple consistent gains along chromosome
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Figure 19. Quantitative Comparison Data for Genomic Imbalances in Ten Cell Lines. The gain threshold was set at a 1.2 copy number ratio, and the loss threshold
was set at a 0.8 copy number ratio. Light gray bars to the right of the ideogram represent gains in a specific chromosomal region for each cell line, and
dark gray bars to the left of each ideogram represent regions of loss in the cell line genome. The gain and loss bars are paired by cell line, starting with
the pair closest to the ideogram, and then flanking outward. A scale with the numeric code for each cell line, as designated in Table 1, is provided above
each ideogram: 1 = 92-1, 2 = MEL270, 3 = MEL285, 4 = MEL290, 5 = OCM-1, 6 = OCM-3, 7 = OCM -8, 8 = OM431, 9 = OMM1, and 10 = OMM2.3.
Only autosomes are considered in our analysis.
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Figure 20. Minimal Common Regions of Gain and Loss Distilled from CGH Mean Profile Data of Ten Uveal Melanoma Cell Lines. The light gray bars to the
right of the ideogram represent gain, and dark gray bars to the left of the ideogram represent regions of loss, common among at least 50% of the cell
lines. These minimal common regions may denote chromosomal regions related to the development and progression of uveal melanoma. Only
autosomes are considered in our analysis.
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Table 2. A Comparison of Gains Seen in Ten Uveal Melanoma Cell Lines Compared with Previously Reported
Chromosomal Abnormalities in Uveal Melanoma.
Gains Observed in the Current
Study a

a

Cell Lines b

1q21.1 - q21.2
1q21.2

(60%)
(60%)

1,2,3,6,7,8
1,3,4,6,7,8

Gains Reported by CGHa

Reference

1q

(9.1%)

Speicher et al., 1994

6p
6p
6p
6p
6p21 - pter

(45.5%)
(57%)
(42%)
(40%)
(54.5%)

Speicher et al., 1994
Ghazvini et al., 1996
"
Gordon et al., 1994
Speicher et al., 1994

3p13 - p14.1

(50%)

2,5,6,7,10

6p21.2 - p21.3

(50%)

1,2,7,9,10

7p13 - p15.2

(50%)

2,3,6,7,9

7q11.21 - q11.23
7q21.2 - q21.3
7q21.3 - q22.1
7q22.1 - q31.1
7q31.1 - q31.3
7q31.3 - q33
7q34 - q35

(50%)
(60%)
(60%)
(70%)
(50%)
(60%)
(50%)

1,3,4,9,10
1,2,3,7,8,9
1,2,5,7,8,9
1,2,5,6,7,8,9
2,5,7,8,9
2,5,6,7,8,9
1,5,6,8,9

7q

(70%)

Gordon et al., 1994

8q24.1 - q24.2
8q24.2 - q24.3
8q24.3

(60%)
(60%)
(60%)

1,2,4,5,8,10
1,2,5,6,8,10
1,2,5,8,10

8q
8q
8q
8q
8q24 - qter

(54.5%)
(100%, fresh)
(57%, fixed)
(100%)
(63.6%)

Speicher et al., 1994
Ghazvini et al., 1996
"
Gordon et al., 1994
Speicher et al., 1994

11p14 - p15.1

(50%)

3,4,5,7,8

11p

(9.1%)

"

The percentage in parentheses is the frequency of occurrence for a given gain.
See cell line key.

b
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Gains Reported by
Classical Cytogenetics a

6p
6p
6p12 - 6pter

Reference

(46.3%) White et al., 1998b
(25%) Wiltshire et al., 1993
(25%)
"

8q
(48.1%) White et al., 1998b
8
(25%) Wiltshire et al., 1993
8q
(50%)
"
8q13.1 - 8qter (25%)
"

Table 2 (cont’d). A Comparison of Gains Seen in Ten Uveal Melanoma Cell Lines Compared with Previously Reported
Chromosomal Abnormalities in Uveal Melanoma.
Gains Observed in the Current
Study a

a

Cell Lines b

17q11.1 - q11.2
17q21.3 - q22
17q22 - q24
17q24
17q24 - q25

(50%)
(50%)
(80%)
(70%)
(60%)

3,4,5,6,8
1,5,6,7,8
1,2,5,6,7,8,9,10
1,2,5,6,8,9,10
1,2,6,8,9,10

19p13.3 - q12
19q12 - q13.1
19q13.1 - q13.2

(50%)
(60%)
(50%)

1,3,6,7,10
1,3,6,7,8,10
3,6,7,8,10

20p11.1 - q11.1
20q11.1 - q11.2

(50%)
(70%)

1,3,6,7,9
1,3,5,6,7,9,10

20q11.2 - q13.1
20q13.1 - q13.3

(60%)
(50%)

3,5,6,7,9,10
3,5,6,7,9

22q11.1 - q11.2
22q11.2 - q12.1
22q13.2
22q13.3 - qter

(80%)
(90%)
(50%)
(50%)

1,2,4,5,6,7,8,10
1,2,4,5,6,7,8,9,10
1,6,7,8,10
1,6,7,8,10

Gains Reported by CGHa

Reference

17

(18.2%)

Speicher et al., 1994

20

(14%)

Ghazvini et al., 1996

22
22q
22q

(9.1%)
(9.1%, fresh)
(42%, fixed)

Speicher et al., 1994
Ghazvini et al., 1996
"

The percentage in parentheses is the frequency of occurrence for a given gain.
See cell line key.

b
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Gains Reported by
Classical Cytogenetics a

Reference

Table 3. A Comparison of Losses Seen in Ten Uveal Melanoma Cell Lines Compared with Previously Reported Chromosomal
Abnormalities in Uveal Melanoma.
Losses Observed in the
Current Studya

a

Cell Lines b

Losses Reported by CGHa

2q37.3 - qter

(50%)

2,5,8,9,10

3p26 - pter

(50%)

3,4,6,7,8

3
3
3
3
3

4q35 - 4qter

(90%)

1,2,3,4,6,7,8,9,10

4q

5p15.3 - pter

(50%)

2,4,6,7,10

6q14 - q21
6q21 - q22.2
6q22.2 - q23.3
6q23.3 - q25.2
6q25.2 - q26
6q26 - q27
6q27 - qter

(50%)
(60%)
(60%)
(70%)
(60%)
(70%)
(90%)

1,2,6,7,10
1,2,3,6,7,10
1,2,6,7,9,10
1,2,3,6,7,9,10
1,2,3,7,9,10
1,2,3,7,8,9,10
1,2,3,4,5,7,8,9,10

7q36 - qter

(60%)

2,3,4,7,8,10

8p23.3 - pter

(50%)

3,4,6,7,10

8p

(28%)

9p23 - p24
9p24 - pter

(50%)
(90%)

6,7,8,9,10
1,2,4,5,6,7,8,9,10

9p21 - pter
“

10p15.1 - pter
10q26.2 - qter

(70%)
(60%)

2,3,4,6,7,8,10
2,4,7,8,9,10

11q25 - qter

(80%)

1,2,5,6,7,8,9,10

11q23 - qter,
11q

6q
6q
6q

Reference

(45.5%)
Speicher et al., 1994
(57%, fresh) Ghazvini et al., 1996
(85%, fixed)
"
(70%)
Gordon et al., 1994
(57%)
Prescher et al., 1996

Losses Reported by
Classical Cytogenetics a

Reference

3
3
3

(80%)
(50%)
(100%)

White et al., 1998a
White et al., 1998b
Wiltshire et al., 1993

6q
6q
6q12 - 6qter

(46.3%)
(25%)
(25%)

White et al., 1998b
Wiltshire et al., 1993
"

"

8p

(25%)

Wiltshire et al., 1993

(27.3%)
“

Speicher et al., 1994
“

9p
9p23 - 9pter

(25%)
(25%)

"
"

(18.2%)
(42%)

"
Ghazvini et al., 1996

(14%)

Ghazvini et al., 1996

(45.5%)
Speicher et al., 1994
(42%, fresh) Ghazvini et al., 1996
(28%, fixed)
"

The percentage in parentheses is the frequency of occurrence for a given loss.
See cell line key.

b
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Table 3 (cont’d). A Comparison of Losses Seen in Ten Uveal Melanoma Cell Lines Compared with Previously Reported
Chromosomal Abnormalities in Uveal Melanoma.
Losses Observed in the
Current Studya

a

Cell Lines b

12p13.3 - pter

(80%)

1,2,3,4,6,7,8,10

13q34 - qter

(50%)

2,4,6,7,8

14q32.3 - qter

(60%)

2,3,5,7,8,9

16q24 - qter

(50%)

2,7,8,9,10

18p11.31 - pter
18q23 - qter

(80%)
(70%)

2,3,4,6,7,8,9,10
1,2,4,7,8,9,10

21q22.3 - qter

(50%)

2,7,8,9,10

Losses Reported by CGHa

Reference

12p

(9.1%)

Speicher et al., 1994

16q

(18.2%)

"

The percentage in parentheses is the frequency of occurrence for a given loss.
See cell line key.

b
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Losses Reported by
Classical Cytogenetics a

Reference

Table 4. A Correlation of Copy Number Abnormalities in Ten Uveal Melanoma Cell Lines and Genes Associated with Uveal
Melanoma or its Predisposing Factors.
Gain/Loss Observed in
Current Studya

Cell Lines b

Gene

+1q21.1 - 1q21.2
+1q21.2

(60%)
(60%)

1,2,3,6,7,8
1,3,4,6,7,8

TNFSF6

-2q31 - q32

(20%)

9,10

+6p21.2 - p21.3

(50%)

1,2,7,9,10

HLA -G

-6q14 - q21

(50%)

1,2,6,7,10

?

-6q21 - q22.2

(60%)

1,2,3,6,7,10

+7q21.2 - q21.3

(60%)

+8q24.1 - q24.2
+8q24.2 - q24.3
+8q24.3

Locus c

Sourcec,d

Function

1q23

tumor necrosis factor ligand

OMIM

transcriptional regulator of alpha4 integrin
subunit gene in metastasis, alpha4 promoter
fused to CAT gene

Larouche et al., 1998

6p21.3

histocompatability antigen

OMIM

6q12 - q21

putative tumor suppressor gene

Copeman, 1992

AIM1

6q21

absent in melanoma

OMIM

1,2,3,7,8,9

MDR1

7q21.1 - q21.2 produces P-gp pump protein, causes drug
resistance in cancer cells

Dunne et al., 1998

(60%)
(60%)
(50%)

1,2,4,5,8,10
1,2,5,6,8,10
1,2,5,8,10

c-myc
"

8q24
"

oncogene
"

Blom et al., 1997
Chana et al.,1999

-9p23 - p24

(50%)

6,7,8,9,10

Singh et al., 1996a

-9p24 - pter

(90%)

1,2,4,5,6,7,8,9,10

tumor suppressor, involved in FAM-M and
Li-Fraumeni
familial cutaneous melanoma critical region

alpha4 integrin 2q31 - q32
subunit gene,
CAT gene

CDKN2 (p16) 9p21
FCM critical
region

9p13 - p22

CMM2

9p21

TYRP1

9p23

cutaneous malignant melanoma, also
involved in FAM-M
tyrosinase-related protein 1

a

Houlston and Damato, 1999
Merbs and Sidransky, 1999
Singh et al., 1996b
OMIM
OMIM

The percentage in parentheses is the frequency of occurrence for a given abnormality.
See cell line key.
c
Loci without an OMIM reference were pinpointed using the International RH Mapping Consortium - GeneMap ’99 at http://www.ncbi.nlm.nih.gov/genemap99.
A number of these loci are not identical to those identified in the current study. The International RH Mapping Consortium recognizes the presence of
positional discrepancies in the published map. Therefore, we have chosen to list these loci due to their linkage with uveal melanoma and their general
proximity to the copy number abnormalities identified in this study.
d
All references to OMIM refer to Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim/ and were collected by doing a keyword search of
“uveal melanoma” and “melanoma.”
b
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Table 4 (cont’d). A Correlation of Copy Number Abnormalities in Ten Uveal Melanoma Cell Lines and Genes Associated
with Uveal Melanoma or its Predisposing Factors.
Gain/Loss Observed in
Current Studya

Cell Lines b

Gene

-10q26.2 qter

(60%)

2,4,7,8,9,10

DMBT1

+11p14 - p15.1

(50%)

3,4,5,7,8

HRAS
"

-11q25 - qter

(80%)

1,2,5,6,7,8,9,10

tyrosinase

-12p13.3 - pter

(80%)

1,2,3,4,6,7,8,10

-13q34 - qter

(50%)

-16q24 - qter

Locus c

Sourcec,d

Function

10q25.3 - q26.1 deleted in malignant brain tumors

OMIM

11p15.5
"

Singh et al., 1996a
OMIM

v-Ha-Ras oncogene
"

11q13.5 - q14.1 melanoma associated antigen

Luyten et al., 1998

KRAS
"

12p12.1
"

Singh et al., 1996a
OMIM

2,4,6,7,8

BRCA2

13q12.2 - q12.3 breast cancer susceptibility locus

Houlston and Damato, 1999

(50%)

2,7,8,9,10

MC1R

16q24.3

melanocortin 1 receptor

OMIM

-17p13 - pter

(30%)

2,9,10

p53

17p13.1

Singh et al., 1996a

+17q11.1 - q11.2
+17q21.3 - q22
+17q22 - q24

(50%)
(50%)
(80%)

3,4,5,6,8
1,5,6,7,8
1,2,5,6,7,8,9,10

NF1
BRCA1
PRKCA

17q11.2
17q21
17q22 - q23.2

tumor suppressor, involved in
Li-Fraumeni
neurofibro matosis
breast cancer
protein kinase C

+19p13.3 - q12
+19q12 - q13.1
+19q13.1 - q13.2

(50%)
(60%)
(50%)

1,3,6,7,10
1,3,6,7,8,10
3,6,7,8,10

STK11
MEL
MIA

19p13.3
19p13.2 - cen
19q13.32 q13.33

serine/threonine protein kinase II
oncogene MEL, Ras-associated protein
melanoma inhibitory activity

OMIM
OMIM
OMIM

+22q11.2 - q12.1

(90%)

1,2,4,5,6,7,8,9,10

EWSR1
LFS
NF2

22q12
22q12.1
22q12.2

Ewing sarcoma breakpoint
Li-Fraumeni
neurofibromatosis

OMIM
OMIM
OMIM

v-Ki-Ras 2 oncogene
"

a

OMIM
OMIM
OMIM

The percentage in parentheses is the frequency of occurrence for a given abnormality.
See cell line key.
c
Loci without an OMIM reference were pinpointed using the International RH Mapping Consortium - GeneMap ’99 at
http://www.ncbi.nlm.nih.gov/genemap99. A number of these loci are not identical to those identified in the current study. The International RH Mapping
Consortium recognizes the presence of positional discrepancies in the published map. Therefore, we have chosen to list these loci due to their linkage with
uveal melanoma and their general proximity to the copy number abnormalities identified in this study.
d
All references to OMIM refer to Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim/ and were collected by doing a keyword search of
“uveal melanoma” and “melanoma.”
b
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3 as a whole. Gains were also seen on 6p and distal 8q, while consistent losses were
found on 6q (Fig. 16). A thorough evaluation of chromosomes 3, 6, and 8 was critical
because they are frequently reported as aberrant in uveal melanoma.

The cell line

MEL285 approached monosomy 3, as a prominent loss extended from the p-terminus to
3q21, but the remainder of the chromosome traced the normal midline of the CGH
profile. Loss of distal 3p was seen in the quantitative comparison data (QCD) (Fig. 19)
for MEL290, OCM3, OCM8, and OM431. Several cell lines exhibited tendencies toward
loss of portions of chromosome 3, including 92-1, MEL290, OCM-3, OCM-8, and
OM431. These tendencies did not exceed the threshold for loss. The trend seen in 92-1
was toward a loss of 3q, whilst the others were for loss of 3p. The p-arm of chromosome
6 was gained in 92-1, MEL270, OMM-1, and OMM-2.3, while 6q was lost in 92-1,
MEL270, MEL285, OCM-3, OCM-8, OMM-1, and OMM-2.3. Three cell lines showed
loss on both 6q and distal 3p (MEL285, OCM-3, and OM431). A focal gain at 8q24 was
also seen in 5 of the 10 cell lines (92-1, MEL290, OCM-1, OCM-3, and OM431). The
entire chromosome 8 was gained in MEL270, while only 8q was gained in OMM-2.3.
Spectral Karyotyping.
SKY identified numerical and structural aberrations on a per-cell basis in each of
the cell lines.

For our SKY analysis, a total of 2,334 chromosome structures were

analyzed, with the percent of aberrations ranging from 0% for the Y chromosome to
62.96% for chromosome 1 (Table 5). Chromosomes 1, 3, 8 and X contained aberrations
in all of the cell lines. Chromosomes 1, 3, 7, 12, 17 and 20 were aberrant more than 50%
of the time collectively across all cell lines.

Frequent structural and numerical

aberrations were tabulated as those that occurred across 3 or more cell lines (Table 5).
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The high frequency of these aberrations suggests that chromosomes 1, 3, 7, 12, 17 and 20
may contain genes of significance in the establishment and/or progression of uveal
malignant melanoma. Chromosomes 1, 3, 8, 17, 19, 20, and 22 were often involved in
numerical aberrations (Table 5).

Complex aberrations involving more than 2

chromosomes were seen frequently in MEL290, OCM-1, OCM-3, and OCM-8 (Fig. 21).
Partially deleted, or truncated, copies of chromosome 3 were seen in OCM-3,
OCM-8, and OM431. There were multiple copies of marker chromosomes in OCM-1
and OM431 that SKY classified as chromosome 3 material. Additional copies of 6p were
found in MEL270 and OCM-8, and additional copies of 8q were found in OCM-3 and
OCM-8. There were no (3;6) or (3;8) rearrangements in any of the cell lines.
Five chromosomal aberrations were observed across multiple cell lines (Fig. 22).
The most prevalent abnormalities were +der(1)t(1;10)(q10;q10) (92-1, OCM-8, OM431,
OCM-3, and MEL285) and +der(2)t(2;12)(p10;q10) (92-1, OCM-8, OM431, OCM-3,
and OCM-1), each evidenced in 5 cell lines.

Other interactions, including

+der(20)t(X;20)(?;q?) (OCM-8, OCM-3, OCM-1, and OMM-2.3) and the persistent
reciprocal t(3;10)(p25;q25) (OCM-8, OM431, OMM-2.3, and MEL270), were each seen
in four cell lines. Three distinct rearrangements were seen between chromosomes 3 and
7, but poor banding quality prevented clarification beyond +der(3)t(3;7)(?;?) or
+der(7)t(3;7)(?;?) for these non-reciprocal translocations. These rearrangements between
chromosomes 3 and 7 were seen in OCM-8, OM431, OCM-1, and OMM-1. Note that
the cell line OCM-8 was the only line evidencing some form of all five of these
interactions.
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Table 5. Summary of Aberrations Identified by SKY in Ten Uveal Melanoma Cell
Lines
Chromoso
me

Range Percent
Aberrationsa

Mean Percent
Aberrations

Lines with
Aberrations

Structural Aberrations b

Frequent Aberrations b,c,d

1

25 - 100

62.96

10

t, dic, del, ins, mr

der(1;10) [5]
t(1;2) [3]
der(1;7) [3]
der(1;16) [3]

2

0 – 100

49.29

7

t, dic, del, ins, mr

der(2;12) [5]

t, dic, del, ins, mr

der(3;7)/t(3;7) [5]
t(3;10) [4]

3

16.67 - 66.67

51.43

10

4

0 - 52.63

22.73

7

t, del

5

0 - 88.89

42.54

7

t, del, i

6

0 - 66.67

37.84

8

t, del, i

7
8

0 - 90.63
8.33 - 75

59.90
47.17

9
10

t, dic, del, mr
t, del, i, mr

9

0 - 66.67

25.24

6

t

10

0 - 80

44.74

8

t, ins, del

11

0 - 75

43.65

7

t, ins, del

12

0 - 85.71

61.81

8

t, ins, del

13

0 - 50

22.99

7

t

14

0 - 50

12.64

4

t, mr, R

15

0 - 66.67

27.45

4

t, mr

16
17

0 - 72.73
0 - 100

49.59
57.81

8
8

t, mr
t, mr

18

0 - 46.67

14.94

3

t, mr

19

0 - 75

30.36

7

t, mr

20

0 - 100

57.45

6

t, mr

21

0 - 100

15.15

8

t

22

0 - 57.89

18.10

5

t, i

X

11.11 - 100

46.51

10

t, del

dup(5p) [3]
t(7;17) [3]
der(8;11) [3]

dup(12p) [3]
dup(12q) [3]

der(16;17) [3]

der(20;X) [4]

Y
0 – NDe
0
0
The range of percent aberrations is determined by the number of aberrant copies of a given chromosome in all SKY spreads for a
cell line compared to the number of normal copies of that same chromosome in that same cell line
b
del = deletion, der = derivative, dic = dicentric, dup = duplication, i = isochromosome, ins = insertion, mr = multiple rearrangement,
R = Robertsonian translocation, t = translocation. All nomenclature, except “mr,” according to ISCN 1995.
c
The number in brackets is the number of cell lines in which the particular aberration was identified.
d
Redundancies in the data set have been eliminated.
e
The notation “ND” indicates that there were no observations, normal or aberrant, for that chromosome. There was no data in 92-1,
MEL270, MEL285, MEL290, OCM-1, OCM -3, OM431, and OMM1 for chromosome Y.
a
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A.

-X
-8
-11

B.

-X
-20
-16
-17

-12
-2
-1

C.

-12

-2

-20
-X

-7
-1
-7
-2

D.

-1
-5
-3

-14

-1
-7
-2

-7
-2

-14
-7
-1

-16
-7
-2

Figure 21. Complex Aberrations Detected by Spectral Karyotyping. SKY employs 24 distinctly labeled chromosome -specific probes, thus allowing for the
identification of all the chromosomes involved in complex rearrangements. SKY was performed on 10 uveal melanoma cell lines and revealed
complex chromosomal rearrangements in 4 of the lines: (A) MEL290, (B) OCM-1, (C) OCM-3 and (D) OCM -8.
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A.

B.

C.

+der(1)t(1;10)(q10;q10)
+der(2)t(2;12)(p10;q10)
+der(20)t(X;20)(?;q?)

D.

E.

t(3;10)(p25;q25)
+der(3)t(3;7)(?;?)

+der(7)t(3;7)(?;?)
Figure 22.

Chromosome Rearrangements Seen Across Ten Uveal Melanoma Cell Lines. (A) A
+der(1)t(1;10)(q10;q10) was seen in 92-1, OCM-3, OCM-8, OM431 and MEL285. (B ) A
+der(2)t(2;12)(p10;q10) was seen in 92-1, OCM-1, OCM-3, OCM-8 and OM431. Note that
these interactions were observed in 5 cell lines each. (C) The cell lines OCM -1, OCM-3,
OCM-8 and OMM2.3 all evidenced a +der(20)t(X;20)(?,q?). (D) Four cell lines (MEL270,
OCM-8, OM431 and OMM2.3) exhibited the reciprocal t(3;10)(p25;q25). (E) Additional
interactions involving chromosome 3, all between chromosomes 3 and 7, were seen as 2
distinct +der(3)t(3;7)(?,?) and a +der(7)t(3;7)(?;?) that were not elucidated by banding
analyses. These interactions all occurred in OCM -1, OCM-8, OM431 and OMM1. Note that
the only cell line containing some form of all five of these interactions was OCM-8.
Interactions observed in multiple cell lines, such as these, are likely linked to the
development of their associated cell line, and warrant further study. These interactions are
also likely associated with copy number abnormalities in the genome, which lead to
enhanced or diminished gene products during development.
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Interphase Fluorescence in situ Hybridization.
Locus-specific FISH probes for 3p, 3q, and 3cen allowed further study of
chromosome 3 in the cell lines (Table 6). Two hundred nuclei were scored at random for
each probe and each cell line. In the diploid control, 86% of the normal male nuclei
analyzed had 2 signals for 3cen. Our cell lines were heterogeneous in chromosome 3
complement according to centromeric-FISH, showing 0 to 6 copies of 3cen (Table 6),
and averaging 0.99 to 1.53 copies per cell. The percentage of 3cen loss (0 or 1 copies
present) was highest in MEL285 (72.5%) and lowest in OCM-1 (49.5%). The dominant
population in each cell line had one 3cen hybridization signal per nucleus (ranging from
34% of cells for 92-1 to 45.5% of cells for MEL285). Meanwhile, gain of signal (≥ 2
copies) ranged from 2.5% (OMM-1) to 19% (OCM-3) by centromeric-FISH.
Results for the telomere probes of the diploid control showed that 93% of cells
had 2 signals for both 3p and 3q. However, we saw a broad range of signals for 3p (0 to
10 copies) and 3q (0 to 12) in individual cells across all cell lines (Table 6). In contrast to
the FISH findings for 3cen, no more than 16% of nuclei had one 3p signal and no more
than 4% had one 3q signal (both seen in MEL290). Four cell lines had at least two 3p
and/or two 3q signals in every cell scored (Table 6).
Comparison of Techniques.
A quantitative analysis was used to determine the relationship between CGH,
SKY and FISH.

Measurements of relative balance were generated from pixel

quantification in CGH and SKY to show the association between the 2 techniques for all
chromosomes (Fig. 23). Regression analysis of this data revealed significant association
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Table 6. Chromosome 3 FISH Signals for Ten Uveal Melanoma Cell Lines
Cell Line

3cen ± SE

3cen Range a

3p ± SE

3p Range a

3q ± SE

3q Range a

FISH RCE b ± SE

Control

2.04 ± 0.03

0 -4

1.99 ± 0.02

1 -3

1.96 ± 0.02

0 -3

1.99 ± 0.01

92-1

1.23 ± 0.07

0 -4

4.14 ± 0.05

2 -6

3.76 ± 0.04

2 -5

3.05 ± 0.06

MEL270

1.12 ± 0.07

0 -3

3.10 ± 0.07

0 -6

3.21 ± 0.06

0 -7

2.48 ± 0.05

MEL285

1.06 ± 0.06

0 -3

2.41 ± 0.06

0 -6

3.08 ± 0.05

0 -8

2.18 ± 0.05

MEL290

1.53 ± 0.07

0 -4

2.03 ± 0.06

0 -6

2.26 ± 0.04

1 -5

1.94 ± 0.04

OCM-1

1.50 ± 0.06

0 -4

4.90 ± 0.07

1 - 10

5.45 ± 0.07

3 - 11

3.95 ± 0.08

OCM-3

1.50 ± 0.08

0 -5

2.96 ± 0.06

0 -7

4.37 ± 0.08

0 -9

2.94 ± 0.06

OCM-8

1.21 ± 0.07

0 -6

3.29 ± 0.06

2 -7

4.64 ± 0.09

2 - 12

3.05 ± 0.07

OM431

1.31 ± 0.07

0 -6

3.98 ± 0.04

2 -6

5.51 ± 0.07

0 - 11

3.60 ± 0.08

OMM1

0.99 ± 0.06

0 -3

3.03 ± 0.04

1 -6

3.04 ± 0.05

0 -7

2.35 ± 0.05

OMM2.3

1.13 ± 0.06

0 -5

4.34 ± 0.07

2 -9

4.22 ± 0.07

2 -9

3.23 ± 0.07

a

The range provided for 3p, 3q, and 3cen is the span of total hybridization signals observed in each of
the cell lines and the control.
b
FISH RCE was calculated by averaging the values in the 3cen, 3p and 3q columns for each cell line.
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between CGH RB and SKY RB for all 22 autosomes across the 9 analyzable cell lines (R
= 0.6146, p = 6.513 x 10-21 ). Correlation of CGH and SKY was also seen visually,
wherein gain and loss in the CGH profile mirrored specific numerical and structural
aberrations in SKY (Fig. 24, note chromosomes 3, 6 and 8).
Of particular interest, were the CGH and SKY correlations in chromosomes 3, 6
and 8, as well as SKY and FISH correlations for chromosome 3 (Fig. 25 and Table 7).
Correlation of SKY RCE and FISH RCE for chromosome 3 demonstrated good
agreement between the two measurements of copy number (R = 0.7370, p = 0.0235) (Fig.
25A), and further correlation of FISH and SKY was also evident visually in the cell line
OCM-1 (Fig. 26). The CGH RB:SKY RB comparison for chromosome 3 also showed
significant correlation (R = 0.6775, p = 0.0449) (Fig. 25B). Correlations for chromosome
6 (R = 0.6825, p = 0.0428) and chromosome 8 (R = 0.8242, p = 0.0063) were both
significant (Figs. 25C and D).
TUMOR STUDY.
Comparative Genomic Hybridization.
Eighty-two of the 100 cases (46 male, 36 female) were successfully extracted,
labeled via DOP-PCR, hybridized, and analyzed. Probe constructs from the remaining 18
DNA isolates were unsuccessful in yielding results, due to a failure to either amplify or
hybridize appropriately.
Results for all 82 tumors were evaluated by comparison of the mean ratio profiles;
numerous consistencies were found throughout the data and used to derive the minimal
common regions as a means of simplifying the data set (Figs. 27, 28 and 29). These

87

Figure 23. Overall Comparison of Calculated CGH RB and SKY RB Values for the 22 Autosomes in Nine
Cell Lines. OCM-3 was excluded fro m this analysis due to inadequate SKY data. The equation
for the regression line is provided in the upper left hand corner with the R2 -value and p-value
immediately below. The y-axis reflects the transformation of internally normalized SKY data
into SKY RB values, which converts them from an absolute measure of copy number to a more
relative measure comparable to CGH. Transformed CGH data (CGH RB) is plotted on the xaxis. Deviation from the regression line is partially explainable by the inherent difference
between the two techniques, as CGH is a genomic average from a pooling of cells and SKY
analysis is performed on per-cell basis with results taken from a few metaphase spreads.
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Figure 24.

Visual Comparison of CGH and SKY. (A) These examples show how the numerical
aberrations in SKY (right) correspond to whole chromosome amplification in CGH (left).
Balanced structural aberrations such as the t(3;10) in OMM2.3 essentially result in a
numerical aberration leading to additional complete copies of chromosome 3. Addition of an
entire chromosome, as seen in chromosome 7 from OMM1 (a pseudodiploid cell line), also
result in amplification along the length of the CGH ratio profile. (B) These examples
demonstrate correlation between CGH mean ratio profiles and unbalanced structural
aberrations in SKY. The presence of a normal chromosome 1, a 1q, and a der(1;10q) result
in gain of 1q and loss of 1p in CGH of MEL285. The der(1;10q) adds additional 10q
material mirrored by the relative loss of 10p and gain of 10q in CGH. In the next example
the gain of 6p and loss of 6q in CGH are mirrored by the 2 normal chromosomes 6 (left) and
an iso(6p) (right) in SKY. Two normal chromosomes 8 (first 2) accompanied by 2 copies of
8q (second 2) as seen in SKY, result in a relative deficit of 8p and a gain of 8q by CGH in
OMM2.3. In the final example, SKY reveals 2 normal copies each of chromosomes 12 and
17, and 2 copies of a der(12q;17q) that explain the amplification of 17q and loss of 12p seen
in the CGH profile of cell line 92-1.
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Figure 25. Comparisons of FISH, SKY and CGH Results for Chromosomes 3, 6, and 8, the Three
Chromosomes Most Frequently Implicated in Uveal Melanoma. These plots, with
trendlines, resulted from the analysis of 9 cell lines, as the cell line OCM -3 was not available
for analysis due to a hardware failure during archiving of the data. The regression equations,
R2 -values, and p-values for each correlation are provided in the upper left-hand corer of each
plot. (A) This plot depicts the correlation of SKY RCE and FISH RCE for chromosome 3.
Copy number values are read directly from the axes for each technique. (B) This plot
represents the correlation calculated between SKY RB and CGH RB values for chromosome
3. Similar correlations between SKY RB and CGH RB are shown for chromosomes 6 (C)
and 8 (D).
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Table 7. Comparison of CGH, SKY and FISH in Relative Balance (RB) and Relative
Chromosome Equivalents (RCE) for Chromosomes 3, 6 and 8
Chromosome 3

Chromosome 6

Chromosome 8

Cell Line

CGH RB

SKY RB

SKY RCE

FISH RCE

CGH RB

SKY RB

CGH RB

SKY RB

92-1

1.03 ± 0.06

1.02 ± 0.11

3.66 ± 0.58

3.05 ± 0.06

1.03 ± 0.03

1.00 ± 0.05

1.40 ± 0.06

1.65 ± 0.08

MEL270

1.29 ± 0.05

1.15 ± 0.03

3.57 ± 0.14

2.48 ± 0.05

1.16 ± 0.03

0.86 ± 0.09

1.62 ± 0.05

1.53 ± 0.06

MEL285

0.88 ± 0.04

0.87 ± 0.10

2.30 ± 0.25

2.18 ± 0.05

0.86 ± 0.03

0.49 ± 0.08

1.08 ± 0.03

1.06 ± 0.10

MEL290

0.93 ± 0.03

0.99 ± 0.06

1.99 ± 0.12

1.94 ± 0.04

0.95 ± 0.02

0.99 ± 0.05

1.05 ± 0.02

0.92 ± 0.03

OCM-1

1.25 ± 0.03

0.97 ± 0.04

3.45 ± 0.13

3.95 ± 0.08

0.99 ± 0.02

0.56 ± 0.01

1.12 ± 0.02

1.08 ± 0.02

OCM-3

1.20 ± 0.04

NDa

NDa

2.94 ± 0.06

0.96 ± 0.02

NDa

1.17 ± 0.06

NDa

OCM-8

1.14 ± 0.04

0.98 ± 0.06

3.05 ± 0.15

3.05 ± 0.07

0.92 ± 0.02

0.87 ± 0.05

1.12 ± 0.05

1.27 ± 0.03

OM431

1.28 ± 0.05

1.35 ± 0.07

4.52 ± 0.26

3.60 ± 0.08

1.04 ± 0.02

0.98 ± 0.09

1.25 ± 0.05

1.05 ± 0.11

OMM1

1.19 ± 0.08

1.30 ± 0.03

2.97 ± 0.06

2.35 ± 0.05

1.16 ± 0.07

0.67 ± NDa

1.13 ± 0.04

0.93 ± 0.15

OMM2.3

1.29 ± 0.05

1.58 ± 0.06

4.56 ± 0.17

3.23 ± 0.07

0.91 ± 0.02

0.68 ± 0.08

1.35 ± 0.06

1.44 ± 0.15

a

ND indicates “No Data.” OCM-3 was the cell line eliminated from the SKY analysis. This value is also given as the
standard error for chromosome 6 in OMM1, because there was only one spread bearing a chromosome 6 for that cell
line.
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Figure 26. Visual Comparison of FISH and SKY. During the scoring of telomere probes (3p = green, 3q =
red) in interphase FISH of OCM-1, we happened upon a metaphase spread that was particularly
illustrative regarding the amount and the arrangement of chromosome 3 telomere material. (A)
A digital image of the metaphase spread, where the yellow, red, and blue arrows indicate the 3
aberrant chromosomes. (B) All of the chromosome 3 material in the metaphase spread is
grouped following image processing. (C) Inversion of the DAPI images for the chromosomes
in (B) revealed a banding pattern that allowed accurate determination that these examples from
FISH and SKY (D) were equivalent. Analysis reveals there are 2 normal copies of
chromosome 3, a third potentially abnormal copy, a der(3p;7) (yellow arrow), a der(3q;7) (red
arrow), and a truncated copy of 3q (blue arrow).

92

regions were those copy number abnormalities identified in greater than 30% but fewer
than 70% of all tumor cases. Any copy number abnormality seen in less than 30% of the
cases is likely not a strong indicator of prognosis.

Conversely, those abnormalities

present in greater than 70% of the cases are not of prognostic significance, since they are
likely commonalities among all cases of uveal melanoma rather than predictive of
outcome.
Within the minimal common regions, differential gain and loss was observed
between male and female cases on the sex chromosomes (Figs. 28 and 29). The data was
further subdivided into minimal common regions for those who survived 9 years or more
post-diagnosis, and those that succumbed to the disease in that time frame (Figs. 30 and
31). Additionally, the sex chromosomes were evaluated independently for male and
female subsets within the live and dead cohorts (Fig. 32). The 25 male patients who
succumbed to the disease evidenced a +Xq21 not seen in the 21 male patients who
survived beyond 9 years post-diagnosis, but no difference was seen on the X
chromosome in the female cases (Fig. 32).
Statistical comparison of the live and dead data sets revealed six chromosomal
regions that correlated strongly with a poor prognosis; five evidenced gain (18q11.2,
6q16, 21q11.2, 9q12 and 3q12), and one showed a loss (1p33). Overall, the strongest
correlation with prognosis was associated with gain of 18q11.2 (p = 0.0037) (Fig. 33).
Gain of 18q11.2 and concomitant loss of 1p33 was the strongest multivariate predictor of
prognosis (p = 0.0028) (Fig. 34).
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Figure 27. Minimal Common Regions of Gain and Loss Distilled from CGH Mean Profile Data of 82 FFPE Uveal Melanoma Cases. The light gray bars to the
right of the ideogram represent gain, and dark gray bars to the left of the ideogram represent regions of loss, common between more than 30% and
less than 70% of the archival cases. These minimal common regions may denote chromosomal regions related to the development and progression of
uveal melanoma. Minimal common regions for the sex chromosomes are provided in Figs. 28, 29 and 32.
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Figure 28. Quantitative Comparison Data and Minimal Common Regions for the Sex Chromosomes of the
Male Archival Cases. (A) The QPD for the X chromosome is shown above the minimal
common regions for that chromosome. Regions of gain and loss, possibly those having
prognostic significance, are shown in the minimal common regions. (B ) The QPD and the
minimal common regions are shown for the Y chromosome.
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Figure 29. Quantitative Comparison Data and Minimal Common Regions for the Sex Chromosomes of the
Female Archival Cases. (A) The QPD for the X chromosome is shown above the minimal
common regions for that chromosome. In greater than 92% of the cases, the entire X
chromosome was lost, eliminating it from having any prognostic significance. (B) The QPD
and the minimal common regions reveal no gains or losses, as expected, in the female cases.
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Figure 30. Minimal Common Regions of Gain and Loss Distilled from CGH Mean Profile Data of 51 FFPE Uveal Melanoma Cases, Representing Those
Patients that Survived Beyond 9 Years Post-diagnosis. The light gray bars to the right of the ideogram represent gain, and dark gray bars to the left
of the ideogram represent regions of loss, common among more than 30% and less than 70% of the archival cases. These minimal common regions
may denote chromosomal regions related to a more favorable prognosis in uveal melanoma. Minimal common regions for the sex chromosomes are
provided in Figs. 28, 29 and 32.
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Figure 31. Minimal Common Regions of Gain and Loss Distilled from CGH Mean Profile Data of 49 FFPE Uveal Melanoma Cases, Representing Those
Patients that Succumbed to Hematogenous Metastasis. The light gray bars to the right of the ideogram represent gain, and dark gray bars to the left
of the ideogram represent regions of loss, common between more than 30% and less than 70% of the archival cases. These minimal common regions
may denote chromosomal regions related to a poor prognosis in uveal melanoma. Minimal common regions for the sex chromosomes are provided
in Figs. 28, 29 and 32.
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Survivors

Deceased
A. MALE

B. FEMALE

-X (>86%)

-X (>91%)

Figure 32. Minimal Common Regions for the Sex Chromosomes, Separated by Gender and Survival. (A) The sex chromosomes for males that survived beyond
9 years with uveal melanoma (23 cases) are compared with the male cases that succumbed to hematogenous metastasis (29 cases). (B) The X
chromosome is compared for the female cases that survived beyond 9 years (28 cases) and those females that succumbed to the disease within that
time period (20 cases).
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Figure 33. Univariate Kaplan-Meier Cause Specific Survival Correlation Curve. This comparative plot
shows the two-fold negative effect on survival that is conferred by the gain of 18q11.2. This
plot was generated from results comprised of all 82 FFPE archival cases in our CGH analysis.
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Figure 34. Multivariate Kaplan-Meier Cause Specific Survival Correlation Curve. This comparative plot
shows the cumulative negative effect on survival that is conferred by the gain of 18q11.2 and
concomitant loss of 1p33. This plot was generated from results comprised of all 82 FFPE
archival cases in our CGH analysis.
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DISCUSSION
Chromosomal rearrangements, both numerical and structural, are often correlated
with morphology, tumor stage, and the aggressive potential of the tumor; therefore, such
aberrations are often of prognostic value (Rothmann et al., 1998).

Some of the

chromosomal rearrangements associated with uveal melanoma have been identified, but
often without being linked to a particular cellular function. Furthermore, the majority of
studies thus far have looked at relatively small populations, and employed cytogenetic
techniques with fairly low resolution. There remains a need for large-scale profiling of
the genomic changes in uveal melanoma, using higher resolution methodologies, in order
to increase and better define the catalogue of cytogenetic aberrations associated with the
disease.

Complete cytogenetic characterization of uveal melanoma is a critical step

toward gene-specific investigation of malignancy.
To that end, we fully characterized 10 uveal melanoma cell lines and 82 archival
FFPE tumors using molecular cytogenetic techniques.

In our cell line study, CGH

revealed genomic imbalances, and SKY provided insight into numerical and structural
abnormalities that contribute to these imbalances in the genome. The tandem application
of CGH and SKY, and the associated synthesis of the results, allowed for a
comprehensive analysis of chromosomal abnormalities in the genome and insight into the
mechanisms of chromosomal aberrations that have accumulated during clonal divergence
(Veldman et al., 1997; Macville et al., 1999). We applied a third technique, FISH, to our
cell lines to assay three specific loci as a practical means of chromosome 3 enumeration.
In our archival tissue study, a thorough evaluation of 82 primary uveal melanoma tumors,
culled from the tissue archives of the AFIP, revealed the specific genomic imbalances
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associated with each tumor, and helped determine regions predictive of prognosis. These
2 studies helped to more fully understand the underlying cytogenetic events of uveal
melanoma development and progression.
CELL LINE S TUDY.
Our research demonstrated that synthesis of CGH and SKY techniques develops
an integrated data set comprised of numerical and structural alterations. Utilizing this
approach, copy number aberrations were localized in chromosomal regions of the 10 cell
lines. These specific regions are likely to contain genes differentially expressed in uveal
melanoma.
CGH provided a comparison of the cell line genomes through evaluation of mean
profile data (Fig. 19), and revealed commonalties in the data set, recorded as minimal
common regions (Fig. 20). These regions are either gained or lost in 50% or more of the
cell lines, and are likely of significance in uveal melanoma. It is thought that within these
regions are the genes that, when their copy number is altered, contribute to the
establishment and/or progression of uveal melanoma.
The definitive numerical and structural composition of individual cell line
genomes was revealed by SKY, and evidence of rearrangement was present within the
chromosome complement of each cell that was analyzed. Reconciliation of multiple
single cell analyses in our SKY results provided an adequate representation of the
genome of each cell line. Comparison of SKY results between the cell lines identified
five common chromosomal abnormalities, each seen in a minimum of four cell lines (Fig.
22).

The prevalence of these aberrations suggests that they are of import to uveal

melanoma development or progression. Our comprehensive SKY analysis revealed
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extensive numerical changes and structural rearrangements in each cell line, which
resulted in aneuploidy, instances of mosaicism, aneusomy and partial chromosome
amplifications and deletions.
Before we could interpret our findings from CGH and SKY, we needed to
determine the correlation between the two techniques. However, there was a caveat to
our interpretation of the CGH and SKY results. A known limitation of CGH is the
inability to elucidate structural information, as only numerical data are gleaned from the
compilation and analysis of mean ratio profiles. Similarly, SKY can not be expected to
reveal all permutations of structural and numerical rearrangement in a cell line, as the
analysis is based on a few analyzable metaphase spreads. With that in mind, we were
able to isolate multiple visual examples where CGH and SKY showed agreement
regarding chromosomal aberrations within a given cell line (Fig. 23).

SKY results

strongly demonstrate that the gains and losses identified by CGH are not exclusively due
to numerical chromosome aberrations. Instead, it is clear that structural rearrangement of
the genome also significantly contributes to amplification and deletion of DNA
sequences.

Complementation between SKY and CGH data is exemplified in the

formation of an isochromosome 6p and concomitant loss of a 6q in MEL270, which
yielded four copies of 6p and only 2 copies of the 6q arm (Fig. 24). This was mirrored in
the CGH results that show a gain of 6p and loss of 6q for that cell line. Also shown in
Figure 24, are additional examples in which genomic imbalances detected by CGH are
mirrored in the SKY analysis from the same cell lines.
An additional feature of SKY, is its ability to resolve complex chromosomal
rearrangements (Fig. 21). While these more complex rearrangements also affect copy

104

number, it is not possible to resolve this by a simple visual inspection of results.
Therefore, we developed mathematical calculations of genomic balance for CGH and
SKY that could be statistically correlated. This quantitative approach for comparing
techniques also served as an independent confirmation of the visual correlation seen
between CGH and SKY.
While visual confirmation of the link between CGH and SKY was intriguing,
demonstration of statistical correlation between the 2 techniques would lend credence to
our observations. Unfortunately, SKY results for OCM-3 were compromised in the data
recovery process, and were omitted from statistical analysis. Comparison of the relative
balance for the 9 remaining cell lines, analyzed by both CGH and SKY, showed
significant correlation across the entire genome, as determined by the associated R2 - and
p-values (Fig. 23). Additionally, chromosome-specific correlations were drawn from
CGH and SKY results for the chromosomes previously reported as having prognostic
value for uveal melanoma (Fig. 25B-D and Table 7). The strength of these quantitative
comparisons confirmed our visual correlations between the two independent in situ
hybridization techniques, and validated our molecular cytogenetic characterizations of the
cell line genomes.
The correlation established between CGH and SKY permitted further
interpretation of the data sets. Several chromosomes (6, 7, 17q and 20q) that showed
imbalance of large continuous sections by CGH in at least half of the cell lines were also
involved in frequent numerical or structural aberrations revealed by SKY (Fig. 20 and
Table 5). The involvement of chromosomes 6 and 7 in uveal melanoma is well
documented in the literature (Gordon et al., 1994; Speicher et al., 1994; Ghazvini et al.,
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1996; White et al., 1998b). Our CGH and SKY results show copy number alteration
events on other chromosomes similar to those in the literature (Tables 2 and 3) (Wiltshire
et al., 1993; Gordon et al., 1994; Speicher et al., 1994; Ghazvini et al., 1996; Prescher et
al., 1996; White et al., 1998a and b). It should be noted that both CGH and SKY
identified alterations of 17q and 20q, neither of which has been previously implicated in
uveal melanoma. We suggest that these chromosomes warrant further study to determine
their significance. The comparison of our data with the published literature suggests our
demonstrated lack of monosomy 3 by CGH or SKY is most noteworthy and requires
explanation.
Application of FISH in a confirmatory capacity following CGH or SKY is a very
powerful application of the technique (Macville et al., 1999).

We used human

chromosome 3-specific centromere and telomere FISH probes on interphase preparations
of all 10 cell lines to confirm our CGH and SKY results for chromosome 3. Our 3cen
hybridizations seemed to indicate loss of chromosome 3, as the dominant population in
each cell line had a single 3cen hybridization signal per nucleus, but the range spanned
from 0 to 6 signals. In contrast, the number of telomere probe hybridization signals
ranged from 0 to 12 signals, with a tendency for 3 or more signals per telomere in each
nucleus. These results indicated a high degree of heterogeneity in the cell lines, and
vastly different chromosome 3 complements than our diploid control (Table 6).
Heterogeneity was also observed in cell line karyotypes from our SKY analyses. The
lack of a major clone in the cell line populations, coupled with the high degree of
heterogeneity observed by SKY and FISH, is suggestive of mo saicism in these cell lines.
The signal variation and enhanced copy numbers for the centromere and telomere probes,
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suggested the presence of enhanced copies of portions of chromosome 3. This is also
shown in the CGH profiles for each cell line, and the numerous rearrangements bearing
chromosome 3 material in our SKY analyses (Figs. 19 and 22E). The distribution of
chromosome 3 material observed in SKY and the partial chromosome 3 gains in CGH,
when considered alongside the FISH results, point toward rearrangement as playing a key
role in chromosome 3 involvement. Visual confirmation of the role of rearrangement
came from a comparison between FISH and SKY findings that show enhanced copy
number for chromosome 3 and define specific rearrangements associated with OCM-1
(Fig. 26).

Further, chromosome-specific correlations show that chromosome 3

rearrangement contributes to copy number enhancement (Fig. 25A and B). Ideally, all
three probes (3cen, 3p and 3q) would have been simultaneously hybridized to determine
the precise assortment of each signal. This would have provided more insight into the
precise mechanism(s) of rearrangement, and also definitively pinpointed mosaicism, but
the hybridization was not technically feasible.
Although monosomy 3 has been heavily reported as a hallmark for uveal
melanoma, our findings for chromosome 3, confirmed using FISH following independent
CGH and SKY analyses, clearly indicate there was no loss of a whole chromosome 3 in
these cell lines.

In contrast to our methodologies, the majority of uveal melanoma

analysis published in the literature is derived from classical cytogenetic evaluations
(Horsman et al., 1990; Sisley et al., 1990; Prescher et al., 1990; Horsthemke et al., 1992;
Sisley et al., 1992; Horsman and White, 1993; Wiltsire et al., 1993; Singh et al., 1994;
Prescher et al., 1994; Prescher et al., 1995; Prescher et al., 1996; White et al., 1998b;
Parada et al., 1999; Sisley et al., 2000; Tschentscher et al., 2001). However, other
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studies have used molecular cytogenetic methods in their determination of monosomy 3,
which indicates that our findings are not linked to our methodologies (Ghazvini et al.,
1996; Prescher et al., 1996; McNamara et al., 1997; Sisley et al., 1997; Tschentscher et
al., 2001). The absence of chromosome 3, 6, and 8 abnormalities in some cases, suggests
there are additional pathways of malignant transformation (Singh et al., 1996a). Thus,
there were indications that there could be alternate explanations for our findings on
chromosome 3.
The search for alternative explanations for our lack of monosomy 3, led to an
examination of cell line origin. Monosomy 3 is frequently reported in tumors of the
ciliary body, whereas a normal or polysomic complement of chromosome 3 is typically
reported in choroidal melanoma (Sisley et al., 1993; McNamara et al., 1997). Our
information regarding cell line origin is incomplete (Table 1), but available information
shows only one cell line (MEL270) was established from a ciliary body tumor. A second
cell line (OMM2.3) was established from a metatstasis of the same primary tumor.
Neither MEL270 nor OMM-2.3 evidenced any loss on chromosome 3 by CGH, while
OMM-2.3 actually demonstrated significant gains on chromosome 3. In fact, only one
cell line (MEL285) demonstrated a considerable loss of chromosome 3 material, and
three other lines (MEL290, OCM-3 and OCM-8) lost only distal 3p material (Fig. 19).
The origin of these four cell lines was indeterminate, which effectively prevented further
correlation between CGH results and cell line origin. SKY results revealed truncated or
partially deleted copies of chromosome 3 in at least three of our cell lines (OCM-3,
OCM-8 and OM431), in addition to normal copies of chromosome 3. The retention of
abnormal copies of chromosome 3 precludes the designation of monosomy to any of

108

these cell lines. Further, FISH results indicate different mean signal counts for each
probe within a cell line, which is not congruent with a determination of monosomy
(Table 6).
Additional investigation regarding the original karyotype, specifically a closer
look at chromosome 3, demonstrated strong parallels between our findings and those
published at the time of establishment. Although establishment karyotypes were only
available for a subset of the cell lines, this investigation was warranted because our cell
lines were of an indeterminate number of passages, and verification of our findings
strengthened any conclusions regarding chromosome 3. The published karyotype for
OCM-1 includes add(3)(q12) and +del(3)(q13q23) (Luyten et al., 1996). The majority of
chromosome 3 was demonstrated to be gained in OCM-1 via CGH, with the exception of
3q13-q23 and distal 3p (Fig. 19). Also, multiple truncated copies of chromosome 3 were
found in our SKY results for OCM-1. The karyotype for OMM-1 indicated a +3[50%] at
the time of establishment, but our CGH results revealed only a 3p gain, and SKY
revealed an apparent trisomy 3 or possibly an isochromosome 3p (Luyten et al., 1996).
Meanwhile, the cell line 92-1 had no known chromosome 3 abnormalities at the time the
cell line was established (DeWaard-Siebinga et al, 1995). There was evidence of a very
small focal 3q13.3 gain in 92-1, and no losses reported along the length of the
chromosome (Fig. 19). Our findings for chromosome 3 demonstrate minimal divergence
from the original karyotype for these 3 cell lines, and the strength of our quantitative
analyses suggests the same would hold true for the remainder of the cell lines (Figs. 23
and 25).
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No expla nation for the lack of monosomy 3 was found in the cell line origin, and
there were no indications were that our cell lines had significantly diverged while in
culture. Based on the strength of the correlations determined for our three techniques, we
sought to reevaluate the literature to elucidate possible discrepancies in data
interpretation between our study and others. Some published reports in the literature,
based upon CGH analyses, have noted a “decreased copy number” for chromosome 3 in
lieu of monosomy. These results provide evidence of a copy number below 1, but the
profile does not cross the loss threshold (Gordon et al., 1994; Ghazvini et al., 1996).
Others have alluded to two tumor suppressor loci, one on the p- and a second on the qarm of the chromosome, which result in focal deletions on chromosome 3 instead of
whole chromosome loss (Sisley et al., 1993; White et al., 1998a; Parella et al., 1999;
Myatt et al., 2000; Tschentscher et al., 2001). In one LOH study, two purported tumor
suppressor loci were defined in terms of the smallest region of overlap (SRO), one within
band 3p25 and the other on the q-arm between 3q24-q26 (Tschentscher et al., 2001). A
second study implicated only 3p24.3 by LOH (Sisley et al., 1993). Two more LOH
studies demonstrated isodisomy of chromosome 3, which may lead to functional
monosomy (White et al., 1996; White et al., 1998a). Comparison of results from CGH
and LOH studies typically results in a high degree of concordance (Ried et al., 1997).
Therefore, the alignment of our findings with those of LOH studies is not surprising.
Elsewhere in the literature, a GTG-banding study reported loss of 3p13 (Blasi et al.,
1999). A later study by Naus and colleagues, who also applied CGH, SKY and FISH to
characterize uveal melanoma, failed to find monosomy 3 but were able to define 3q13q21 as a region of loss (Naus et al., 2001). The findings of Blasi et al. (1999) and Naus
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et al. (2001) suggest a region near band 3q13 may potentially harbor a tumor suppressor
gene. Other findings in the literature, including trisomy 3 and even tetrasomy 3 as
reported by McNamara and colleagues, are supportive of our CGH, SKY and FISH
results that indicate gains on chromosome 3 (Figs. 16, 22 and 23, Tables 6 and 7)
(McNamara et al., 1997). This review of the literature revealed indications that there are
explanations for the involvement of chromosome 3 other than whole chromosome loss.
Another finding of note was the consistent involvement of several specific
chromosomes in structural rearrangements as seen by SKY, which suggests a redundant
mechanism for this occurrence (Fig. 22, Table 5). Our cell lines were shown to have
minimally diverged in culture, therefore cell culture artifacts only account for a small
proportion of these findings.

Each of the five common chromosomal interactions

observed across multiple cell lines, which include several chromosome 3 interactions,
involved chromosomes with deletions in one or both telomeric regions of the
chromosome (Figs. 19 and 22). Other telomeric deletions in specific cell lines were
related to increased structural rearrangement of those same chromosomes in SKY
analysis, and these deletions on the distal p- or q-arms were consistent with the
rearrangement observed in the SKY karyotypes. In general, chromosomes shown to
evidence telomeric deletion in the minimal common regions, also revealed higher
frequencies of structural rearrangements by SKY (Fig. 20 and Table 5). This suggests
that telomeric loss may facilitate structural rearrange ment, but further study would be
required to accurately determine the significance of this finding in the uveal melanoma
cell lines.
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CGH and SKY represent distinct approaches that reveal complementary
information on cytogenetic features of uveal melanoma. Utilizing a combination of
CGH, FISH and SKY we confirmed the absence of monosomy 3 in these ten cell lines,
and demonstrated alternative manifestations of chromosome 3 in this tumor.

Our

findings do not refute the occurrence of monosomy 3 reported by others, but instead we
postulate that frequent rearrangement of chromosome 3 may have an equally important
contribution in the mechanisms driving uveal melanoma. The portion of the study that
followed, a study of archival tissue by CGH, was expected to enha nce resolution of the
critical chromosomal regions throughout the genome and ultimately aid in the
determination of specific gene involvement in uveal melanoma.
TUMOR STUDY.
Classification of tumors based on histopathology and tumor grading is subjective
and qualitative, based on a two-dimensional image analysis (Rothmann et al., 1998).
Classical cytogenetic studies, while useful in elucidating structural abnormalities, are
time consuming and require fresh tissue. Furthermore, classical cytogenetic analysis is
compromised when dealing with solid tumor preparations due to low mitotic indices,
poor growth in culture, etc. (Joos et al., 1994; Houldsworth and Chaganti, 1994; Isola et
al., 1994; Macville et al., 1997; Veldman et al., 1997; Ried et al., 1997; Rothmann et al.,
1998). Techniques such as CGH are expected to yield more information. Our large-scale
CGH study, aimed at determining a set of prognostic indicators in uveal melanoma,
identified specific regions of gain and loss (Figs. 27, 28 and 29). These regions were
initially derived irrespective of the survival correlation portion of the study, thus
indicating regions that may contain genes leading to development of uveal melanoma.
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The CGH data was further subdivided based upon survival correlation (Figs. 30,
31 and 32). Regions containing genes associated with malignancy were revealed in the
survival correlation and associated minimal common regions, and are presumed to be
indicators of prognosis. Statistical analyses confirmed 6 regions of import with regard to
survival. Of these, the most potent predictor of prognosis identified in this study was
18q11.2 (Fig. 33). Multivariate analyses revealed that gain of 18q11.2 combined with the
loss of 1p33 had the most drastic effect on prognosis (Fig. 34).
Application of a Bonferroni correction obfuscates the statistical significance of
our findings. This includes both conservative and rigorous applications of this correction.
This is likely attributable to a relatively small sample size, further subdivided for survival
correlation analysis, for such an application.
There is evidence that suggests gender may be involved in uveal melanoma
susceptibility, as males are slightly more susceptible than females (McLean and Gamel,
1996).

CGH results revealed very different regions of gain and loss on the X

chromosome in a comparison of male and female cases (Figs. 28 and 29). The minimal
common regions revealed that +Xq21 is unique to male patients who succumbed to uveal
malignant melanoma (Figs. 28, 29 and 32). This region was not statistically significantly
different in the analysis, because of the reduction of the sample size required to
simultaneously analyze survival and gender (Fig. 32), but may warrant further study.
Due to the high frequency with which chromosome 3 loss is reported in uveal
melanoma, data interpretation of CGH becomes critical in evaluation of chromosome 3.
A closer look at the published literature revealed some inconsistencies. In some reports,
CGH research has noted a decrease in copy number of chromosome 3 instead of whole
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chromosome loss (Gordon et al., 1994; Ghazvini et al., 1996). In such instances, the
ratio profile indicates a copy number ratio below 1, but does not exceed the loss threshold
in all cases. These results indicate a tendency toward loss, rather than monosomy 3 as
reported (Gordon et al., 1994; Ghazvini et al., 1996).

Chromosome 3 findings in

previously published uveal melanoma studies have revealed contributions of
chromosome 3 other than monosomy. LOH studies have demonstrated loss on either the
p- or q-arm of the chromosome, but not complete loss along the length of the
chromosome (White et al., 1996; White et al., 1998a; Parella et al., 1999). Other LOH
studies have localized various regions of loss to 3p24.3, 3p13, 3p22 (TGFbetaR2 gene
locus), 3p25, and 3q24-q26 (Sisley et al., 1993; Blasi et al., 1999; Myatt et al., 2000;
Tschentscher et al., 2001).
We did not find any instances where the entire CGH ratio profile exceeded the
threshold for loss.

All partial chromosome losses, or tendencies toward loss, were

recorded on interstitial portions of the p- and q-arms. Any observations in the most
proximal and most distal bands of chromosome 3 were not included in this segment of
the analysis, due in large part to the variability in hybridization near the centromere or
telomere. The observed regions of interstitial loss fall within 3p13-p25 and 3q12-q28.
Findings in other studies, particularly involving LOH of chromosome 3, align with our
findings.
A drawback to large-scale CGH is the potential to mask critical chromosomal
regions present in a low frequency within a given sample or within a collection of
samples, and a similar drawback is realized in the distillation of minimal common
regions.

However, correlation of CGH with patient follow-up, using a variety of
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established prognostic factors, has more utility. Using this approach, we have found six
regions shown to be of significance to prognosis, including 18q11.2, 6q16, 21q11.2,
9q12, 3q12, and 1p33. We also identified a region on the X chromosome that seemed to
correlate with a poor prognosis in males, but was not confirmed as statistically
significant. All seven of these regions warrant further study.
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SUMMARY
Our complete characterization of 10 cell lines, and analysis of copy number
imbalances in 82 archival specimens, represents the most extensive and comprehensive
cytogenetic characterization of uveal melanoma to date. In our cell lines, we catalogued
numerous numerical and structural chromosomal aberrations. Many of these aberrations
were suggested by the genomic imbalances revealed in the study of cell line and archival
material.

Chromosomes 1, 3, 7, 12, 17 and 20 were most frequently involved in

numerical or structural aberrations in our SKY analysis, and CGH confirmed substantial
genomic imbalance on each of these chromosomes, suggesting an integral role for these
chromosomes in uveal melanoma.

We were able to determine the involvement of

chromosome 3 in our cell lines, and confirmed that rearrangement of that chromosome is
more prevalent than whole chromosome loss in our samples. Our tumor study identified
several chromosomal regions associated with prognosis, including 18q11.2, 6q16,
21q11.2, 9q12, 3q12, and 1p33. Together, our studies are aimed at directing further
gene-specific study of malignancy in uveal melanoma.
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Cell Culture
RPMI 1640
1 package powdered RPMI 1640 media (Invitrogen Life Technologies, Carlsbad, CA)
2g NaHCO3
1000ml sterile or autoclaved dH2 O
Add powdered media and approximately 900ml sterile/autoclaved dH2 O to 1000ml volumetric flask. Add
2g NaHCO3 , and add a stir bar. When dissolved, pH to 0.2-0.3 below final desired pH (7.0-7.4). Remove
stir bar, and add remainder of dH2 O to reach 1000ml. Using suction filtration, divide flask into two 500ml
sterile bottles. Incomplete media can be stored at -20ºC until needed.
To complete media (each 500ml bottle):
50ml FBS (Sigma Co., St. Louis, MO)
5ml NEAA (Sigma Co., St. Louis, MO)
5ml HEPES Buffer (Sigma Co., St. Louis, MO)
0.5ml gentamicin (Invitrogen Life Technologies, Carlsbad, CA)
0.5-1ml Fungizone (Invitrogen Life Technologies, Carlsbad, CA)
1-2ml penicillin/streptomycin (100U/ml and 100µg/ml, respectively) (Invitrogen Life Technologies,
Carlsbad, CA)
Store completed media at 4ºC in the dark.
DMEM
1 bottle powdered DMEM media (Sigma Co., St. Louis, MO)
3.7g NaHCO3
1000ml sterile or autoclaved dH2 O
Add powdered media and approximately 900ml sterile/autoclaved dH2 O to 1000ml volumetric flask. Add
3.7g NaHCO3 , and add a stir bar. When dissolved, pH to 0.2-0.3 below final desired pH (7.0±0.3).
Remove stir bar, and add remainder of dH2 O to reach 1000ml. Using suction filtration, divide flask into
two 500ml sterile bottles. Incomplete media can be stored at -20ºC until needed.
To complete media (each 500ml bottle):
50ml FBS
5ml NEAA
5ml HEPES Buffer
0.5ml gentamycin
0.5-1ml Fungizone
1-2ml penicillin/streptomycin
Store completed media at 4ºC in the dark.
Ham’s F-12
1 package powdered Ham’s F-12 media (Invitrogen Life Technologies, Carlsbad, CA)
1.176g NaHCO3
1000ml sterile or autoclaved dH2 O
Add powdered media and approximately 900ml sterile/autoclaved dH2 O to 1000ml volumetric flask. Add
1.176g NaHCO3 , and add a stir bar. When dissolved, pH to 0.2-0.3 below final desired pH (7.6-7.9).
Remove stir bar, and add remainder of dH2 O to reach 1000ml. Using suction filtration, divide flask into
two 500ml sterile bottles. Incomplete media can be stored at -20ºC until needed.
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To complete media (each 500ml bottle):
50ml FBS
5ml NEAA
5ml HEPES Buffer
0.5ml gentamycin
0.5-1ml Fungizone
1-2ml penicillin/streptomycin
Store completed media at 4ºC in the dark.

Metaphase Chromosome Preparation
Carnoy’s Fixative
75ml absolute methanol, HPLC grade (Fisher Scientific, Inc., Pittsburgh, PA)
25ml glacial acetic acid, tracemetal grade (Fisher Scientific, Pittsburgh, PA)
Make 3:1 mixture as needed. Use only when fresh (first day).
75mM KCl
5.6g KCl
1000ml dH2 O
Dissolve KCl in dH2 O. Store at room temperature.

DNA Isolation
100mM Tris/Cl pH 8.5
2.21g Tris -HCl (Sigma Co., St. Louis, MO)
4.36g Trizma Base (Sigma Co., St. Louis, MO)
Add Tris -HCL, Trizma base and ~450ml dH2 O to a 500ml volumetric flask with a magnetic stir bar. After
contents are completely dissolved, remove stir bar and fill flask the remainder of the way to the 500ml
mark with dH2 O. Adjust pH to 8.5 and autoclave. Store at room temperature.
Cell Lysis Buffer
20ml 100mM Tris -HCl pH 8.5
2ml 0.5M EDTA pH 8.0 (Digene, Gaithersburg, MD)
4ml 10% SDS (Fisher Scientific, Pittsburgh, PA)
8ml 5M NaCl
165ml dH2 O
Makes 199ml. Store at room temperature.
TE Buffer pH 7.0
5ml 1M Tris -HCl pH 7.0 (Quality Biological, Inc., Gaithersburg, MD)
1ml 0.5M EDTA pH 8.0
494ml dH2 O
Adjust to pH 7.0 and autoclave. Store at room temperature.
RNase A
100mg RNase A, lyophilized (Roche Molecular Biochemicals, Indianapolis, IN)
5ml sterile H2 0 (DNase free, RNase free)
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To dissolve, boil for 15 minutes, and then cool to room temperature. Aliquot 20mg/ml solution, and store
at -20°C. See also “Pretreatment of Slides for CGH, SKY and FISH.”

Nick Translation
NT Buffer
500 µl 0.5M Tris HCl, pH 8.0 (Quality Biological, Inc., Gaithersburg, MD)
100µl 50mM MgCl2
50µl 0.5mg/ml BSA (Sigma Co., St. Louis, MO)
350µl sterile H2 0 (DNase free, RNase free) (Sigma Co., St. Louis, MO)
Makes 1ml. Aliquot and store at -20°C.
DNase I (1mg/ml)
10mg DNase I (Roche Molecular Biochemicals, Indianapolis, IN)
1.5ml 0.15M NaCl (Quality Biological, Inc., Gaithersburg, MD)
5ml 50% Glycerol (Fisher Scientific, Pittsburgh, PA)
10ml sterile H2 0 (DNase free, RNase free)
Aliquot and store at -20°C. Make 1:1000 dilution for use in nick translation reactions.
dNTP Mixture
5µl each of 100mM dATP, dCTP, and dGTP (Promega, Madison, WI)
1µl of 100mM dTTP (Promega, Madison, WI)
984µl sterile H2 0 (DNase free, RNase free)
Makes 0.5mM dATP/dCTP/dGTP and 0.05mM dTTP. Aliquot and store at -20°C.
0.1M β-Mercaptoethanol
34.7µl of 99% (14.4M) solution (Sigma Co., St. Louis, MO)
Sterile H2 0 (DNase free, RNase free) to make 5ml
Aliquot and store at -20°C.
50µl Nick Translation Reaction
xµl (1µg) DNA (volume variable)
5µl 10xNT Buffer
5µl dNTP mixture
5µl 0.1M ß -Mercaptoethanol
2µl biotin- or digoxigenin-11-dUTP
33-xµl sterile H2 O (DNase free, RNase free)

DOP-PCR
DOP-PCR Primer
Resuspend DOP-PCR CGH primer, 5’- GAT CAA GCT NNN NNN ATG TGG - 3’ (Integrated DNA
Technologies, Inc., Coralville, IA) in 1223.7µl sterile H2 O (DNase free, RNase free) to make 100mM
primer stock.
Dilute primer stock 1:5 in sterile H2 O (DNase free, RNase free) to make 20mM primer.
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Biotin- or dig-dNTP Mixture
3.04µl dATP
3.04µl dCTP
3.04µl dGTP
1.26µl dTTP
25µl biotin- or dig-dUTP (Roche Molecular Biochemicals, Indianapolis, IN)
117µl sterile H2 O (DNase free, RNase free)
Makes 152µl dNTP mix. Make fresh as needed.
DOP-PCR Polymerase
250U AmpliTaq Gold Polymerase stock, 5U/µl (Roche Applied Biosystems, Foster City, CA)
50µl sterile H2O (DNase free, RNase free)
Make 1:1 dilution (2.5U/µl) of AmpliTaq Gold Polymerase before use, by adding 50µl sterile H2O to 50µl
AmpliTaq Gold stock.
DOP-PCR Master Mix (MM)
10µl 10xBuffer II (Roche Applied Biosystems, Foster City, CA)
10µl 20mM DOP Primer (Integrated DNA Technologies, Inc., Coralville, IA)
24µl 25mM MgCl2 (Roche Applied Biosystems, Foster City, CA)
5µl biotin- or dig-dUTP mixture
39µl sterile H2 O (DNase free, RNase free)
2µl AmpliTaq Gold Polymerase
Makes 90µl MM, which is enough for a single DOP-PCR reaction. Scale as needed, allowing for a single
extra reaction in case of error. Make fresh as needed and keep on ice.
100µl DOP-PCR Reaction
10µl DNA
90µl DOP-PCR MM
Reaction Conditions:
95°C for 10 minutes, initial soak
15 cycles:
94°C for 1 minute
30°C for 1 minute
72°C for 1 minute
60 cycles (with a 1 second per cycle addition to each step in the 60 cycles):
94°C for 30 seconds
52°C for 30 seconds
72°C for 1 minute
Final extension of 72°C for 10 minutes
Hold at 4°C.

Electrophoresis
1.7% Agarose Gel
0.85g low melting point agarose powder (Invitrogen Life Technologies, Carlsbad, CA)
50ml 1x TBE buffer (Invitrogen Life Technologies, Carlsbad, CA)
Microwave (boil) until dissolved. Cool to ~65°C in a water bath and mix in 2.5ml of a 10mg/ml ethidium
bromide solution. Pour gel or store at 4°C in the dark.
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Gel-Loading Buffer III (6x)
0.025g bromophenol blue (Sigma Co., St. Louis, MO)
0.025g xylene cyanol (Sigma Co., St. Louis, MO)
3ml glycerol
6.95ml dH2 O
Final solution is 0.25% bromophenol blue, 0.25% xylene cyanol, and 30% glycerol in dH2 O. Store at 4°C.

Pretreatment for CGH, SKY and FISH
2xSSC
10ml 20xSSC (Fisher Scientific, Pittsburgh, PA)
90ml dH2 O
Store at room temperature.
1xPBS
10ml 10xPBS (w/o MgCl2 or CaCl2 ) (Invitrogen Life Technologies, Carlsbad, CA)
90ml dH2 O
Store at room temperature.
1M MgCl2
203.3g MgCl2 •6H2 0 (Fisher Scientific, Pittsburgh, PA)
1000ml dH2 O
Add MgCl2 •6H2 0 and ~800ml dH2 O to a 1000ml volumetric flask with a stir bar. Remove stir bar and fill
flask to 1000ml. Aliquot and autoclave. Store at room temperature.
1x PBS/MgCl2
50ml 1M MgCl2
950ml 1xPBS (w/o MgCl2 or CaCl2 )
Store at room temperature.
RNase A
100mg RNase A, lyophilized (Roche Molecular Biochemicals, Indianapolis, IN)
5ml sterile H2 0 (DNase free, RNase free)
To dissolve, boil for 15 minutes, and then cool to room temperature. Aliquot 20mg/ml solution, and store
at -20°C. Make 1:200 dilution in 2xSSC for slide pretreatment.
Pepsin stock solution
100mg pepsin (Sigma Co., St. Louis, MO)
1ml sterile H2 0 (DNase free, RNase free)
Dissolve, keep on ice. Make 50µl aliquots of 100mg/ml stock solution, and store at -20°C.
0.01M HCl
1ml 1M HCl (Fisher Scientific, Pittsburgh, PA)
99ml dH2 O
Store at room temperature.
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Pepsin/HCl
15µl pepsin stock solution
100ml 0.01M HCl
Make fresh as needed with HCl pre-warmed to 37°C.
1% Formaldehyde in 1xPBS/MgCl2
2.7ml of 37% Formaldehyde solution (Fisher Scientific, Pittsburgh, PA)
100ml 1xPBS/MgCl2
Store at room temperature.

Hybridization for CGH, SKY and FISH
Master Mix (MM)
1g dextran sulfate sodium salt (Biotech grade) (Fisher Scientific, Pittsburgh, PA)
5ml 2xSSC
Dissolve dextran sulfate in 2xSSC at 70°C for several hours. Once dissolved, cool to room temperature and
adjust to pH 7.0. Aliquot, store at -20°C.
70% FA/SSC for CGH slide denaturation
7ml formamide, molecular grade (Fisher Scientific, Pittsburgh, PA)
1ml 20xSSC
2ml sterile H2 0 (DNase free, RNase free)
Adjust to pH 7.2-7.3. Store at -20°C.
70% FA/SSC for FISH slide denaturation
35ml formamide, molecular grade
5ml 20xSSC
10ml sterile H2 O (DNase free, RNase free)
Adjust to pH 7.0. Store at 4°C for up to 3 weeks.
Probe Precipitation for CGH
30µl each (tumor and reference) DOP-PCR product
60µl human Cot-1 DNA (Invitrogen Life Technologies, Carlsbad, CA)
1µl salmon testes DNA (Sigma Co., St. Louis, MO)
12.1µl 3M sodium acetate
400µl absolute ethanol, ice cold

Detection for CGH, SKY and FISH
50% FA/SSC
30ml 20xSSC
120ml dH2 O
150ml formamide, molecular grade
Make one day before needed. Adjust to pH ~7.25.
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4xSSC/0.1% Tween 20 for CGH
100ml 20xSSC
400ml dH2 O
0.5ml Tween 20 (Sigma Co., St. Louis, MO)
Store at room temperature.
4xSSC/0.05%Tween 20 for FISH
100ml 20xSSC
400ml dH2 O
0.25ml Tween 20
Store at room temperature.
1xSSC for SKY
25ml 20xSSC
Add 475ml dH2 O to make 500ml
0.1xSSC
2.5ml 20xSSC
Add dH2 O (~497.5ml) to make 500ml
0.4xSSC
10ml 20xSSC
Add dH2 O (490ml) to make 500ml
Store at room temperature.
3% BSA for CGH
0.3g bovine serum albumin (BSA) powder (Sigma Co., St. Louis, MO)
10ml 4xSSC/0.1%Tween 20
Dissolve BSA in 4xSSC/Tween 20 to make 3% blocking solution. Store at 4°C.
1% BSA for Antibody Layering in CGH
Dilute 3% BSA 2:1 in 4xSSC/0.1%Tween 20
Used in antibody dilution for detection layers in CGH. Store at 4°C.
3% NFDM for FISH
1 bottle lyophilized NFDM (Sigma Co., St. Louis, MO)
100ml dH2 O
0.2% sodium azide
Reconstitute NFDM in dH2 O. Add 200µl sodium azide as a preservative. Makes 3% blocking solution.
Also used in antibody dilution for detection layers in FISH. Store at 4°C.
Antibody Layers for CGH
1)
2)
3)
4)

avidin-FITC (1:200), mouse anti-dig (1:100), in 1% BSA
anti-avidin (1:200), rabbit anti-mouse TRITC (1:200), in 1% BSA
avidin-FITC (1:200), in 1% BSA
goat anti-rabbit TRITC (1:200), in 1% BSA

1% BSA is dilution of 3% BSA blocking solution for CGH. Prepare 200µl of each layer per slide. Make
fresh.
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Antibody Layers for FISH
1)
2)
3)

avidin-FITC (1:400), avidin-Rhodamine (1:400), in 3% NFDM
anti-avidin (1:100), in 3% NFDM
avidin-FITC (1:400), avidin-Rhodamine (1:400), in 3% NFDM

3% NFDM is also used in blocking layer for FISH. Prepare 200µl of each layer per slide. Make fresh.
DAPI
2mg DAPI (Roche Molecular Biochemicals, Indianapolis, IN)
10ml 2xSSC
Dissolve DAPI in 2xSSC to make 2mg/ml DAPI stock solution. Working solution is 80ng/ml. To make
working solution, add 4µl DAPI stock solution to 50ml 2xSSC.
0.5M carbonate buffer
6.2g Na 2 CO3 ·H2 O or 5.3g Na 2 CO3 (Sigma Co., St. Louis, MO)
autoclaved dH2 O to complete 100ml
Dissolve to make 100ml of 0.5M Na 2 CO3 .
0.5M bicarbonate buffer
4.2g NaHCO3 (Sigma Co., St. Louis, MO)
autoclaved dH2 O to complete 100ml
Dissolve to make 100ml of 0.5M NaHCO3 .
0.5M carbonate-bicarbonate buffer
10ml 0.5M Na 2 CO3
90ml 0.5M NaHCO3
Adjust to pH 9.0. Store at room temperature.
Antifade
100mg phenylenediamine dihydrochloride (Sigma Co., St. Louis, MO)
10ml 1xPBS (w/o MgCl2 or CaCl2 )
90ml glycerol
Dissolve phenylenediamine dihydrochloride in 1xPBS, and sterile filter solution. Adjust pH to 8.0 with
0.5M carbonate-bicarbonate buffer (pH 9.0), and add 90ml glycerol for a total volume of approximately
110ml. Store at -20ºC in the dark (may be useful to wrap bottle in aluminum foil to avoid degradation
when using it at room temperature).
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A.

B.

C.

D.

Figure 35. Image Capture for CGH Analysis from an Archival Uveal Melanoma Case. Each of these
images is the identical normal male metaphase spread detected with three different fluorescent
filters. (A) The metaphase chromosomes counterstained with DAPI. Biotinylated tumor DNA
and dig-11-dUTP-labelled normal DNA signals were detected with avidin-conjugated
fluorescein isothiocyanate (FITC) and tetramethylrhodamine isothiocyanate (TRITC)
conjugated antibodies. (B) The FITC image, and (C) The TRITC image. These three
fluorescent images (A, B and C) combine to form the completed CGH image seen in (D). This
newly combined image is suitable for CGH analysis; the image is classified and karyotyped,
followed by the generation of CGH profiles to illustrate the amplifications and deletions
present within the tumor genome.
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Figure 36. An Example of CGH Profile Data. The Leica image analysis software (Leica Inc., Exton, PA) generates 95% confidence intervals for mean CGH
profile data once each metaphase has been appropriately karyotyped. This profile data is from case 39, a male patient. A minimum of ten metaphase
spreads were collated to generate the mean data for each of the cases. Using the profiles from each of the spreads that combine to form the mean for
each case, the software is able to calculate these confidence intervals for the mean profile data. The color chromosome image to the left of each
ideogram (from Fig. 35D) was generated using the combination of all three fluorescent filters seen in Figs. 35A, B, and C. It should be noted that in
the case data represented above, the profile data for the chromosomes have relatively narrow confidence intervals, which lends credence to the values
of the mean. Simplified, the less variation (width) in the confidence interval, the greater certainty that can be assigned to the relative copy numbers
in the data. This kind of data is generated for the mean profile data for the data set of each case during analysis.
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A.

B.

C.

D.

Figure 37. Interphase FISH Control Using Centromere Probe for Chromosome 3. (A ) The isolated
nucleus is counterstained with DAPI. (B) The FITC and (C) the TRITC images represent the
dual-color fluorescence visualization of the centromere probe, ensuring distinction of the
signal from the background. (D) The overlay shows 2 yellow signals that confirm the 2
signals visualized are in fact the centromere probe and not background noise. The overlay
also confirms that the control nucleus in this image is in fact normal.
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A.

B.

C.

Figure 38. Interphase FISH Control Using Telomere Probes for 3p and 3q. (A) The 3p probes are
visualized with FITC. (B) The 3q probes are visualized with TRITC. (C) The overlay of
FITC and TRITC probes on a DAPI counterstain confirms 2 signals per cell for the control
nuclei.
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A.

B.

C.

D.

E.

Figure 39. Telomere Probe Signals (3p and 3q) in Uveal Melanoma Cell Lines. Examples from the cell
line (A) MEL270; (B) MEL285 ; (C) MEL290; (D) OCM-1; (E) OCM-3.
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